{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T13:42:42Z","timestamp":1792590162514,"version":"4.5.0"},"reference-count":356,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:00:00Z","timestamp":1792540800000},"content-version":"vor","delay-in-days":90,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2024\/21624-7"],"award-info":[{"award-number":["2024\/21624-7"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2023\/12246-6"],"award-info":[{"award-number":["2023\/12246-6"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["305758\/2021-7"],"award-info":[{"award-number":["305758\/2021-7"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cancer"],"DOI":"10.1186\/s12943-026-02749-9","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T07:08:18Z","timestamp":1784790498000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ribosome biogenesis and selective translational control as oncogenic vulnerabilities in hematologic malignancies"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8384-6551","authenticated-orcid":false,"given":"Juan Luiz","family":"Coelho-Silva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2937-8109","authenticated-orcid":false,"given":"Jo\u00e3o Agostinho","family":"Machado-Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,23]]},"reference":[{"key":"2749_CR1","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nature10098","volume":"473","author":"B Schwanh\u00fcusser","year":"2011","unstructured":"Schwanh\u00fcusser B, Busse D, Li N, Dittmar G, Schuchhardt J, Wolf J, et al. Global quantification of mammalian gene expression control. Nature. 2011;473:337\u201342. https:\/\/doi.org\/10.1038\/nature10098. [cited 2026 Mar 29].","journal-title":"Nature"},{"key":"2749_CR2","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/345544a0","volume":"345","author":"A Lazaris-Karatzas","year":"1990","unstructured":"Lazaris-Karatzas A, Montine KS, Sonenberg N. Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5\u2019 cap. Nature. 1990;345:544\u20137. https:\/\/doi.org\/10.1038\/345544a0. [cited 2026 Mar 29].","journal-title":"Nature"},{"key":"2749_CR3","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/nm1042","volume":"10","author":"D Ruggero","year":"2004","unstructured":"Ruggero D, Montanaro L, Ma L, Xu W, Londei P, Cordon-Cardo C, et al. The translation factor eIF-4E promotes tumor formation and cooperates with c-Myc in lymphomagenesis. Nat Med. 2004;10:484\u20136. https:\/\/doi.org\/10.1038\/nm1042. [cited 2026 Mar 29].","journal-title":"Nat Med"},{"key":"2749_CR4","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/nature02369","volume":"428","author":"HG Wendel","year":"2004","unstructured":"Wendel HG, De Stanchina E, Fridman JS, Malina A, Ray S, Kogan S, et al. Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy. Nature. 2004;428:332\u20137. https:\/\/doi.org\/10.1038\/nature02369. [cited 2026 Mar 29].","journal-title":"Nature"},{"key":"2749_CR5","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/nrc.2016.27","volume":"16","author":"ML Truitt","year":"2016","unstructured":"Truitt ML, Ruggero D. New frontiers in translational control of the cancer genome. Nat Rev Cancer. 2016;16:288\u2013304. https:\/\/doi.org\/10.1038\/nrc.2016.27. [cited 2026 Mar 29].","journal-title":"Nat Rev Cancer"},{"key":"2749_CR6","doi-asserted-by":"publisher","unstructured":"Robichaud N, Sonenberg N, Ruggero D, Schneider RJ. Translational Control in Cancer. Cold Spring Harb Perspect Biol. 2019;11. https:\/\/doi.org\/10.1101\/cshperspect.a032896. [cited 2026 Mar 29].","DOI":"10.1101\/cshperspect.a032896"},{"key":"2749_CR7","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/nrc2819","volume":"10","author":"J Van Riggelen","year":"2010","unstructured":"Van Riggelen J, Yetil A, Felsher DW. MYC as a regulator of ribosome biogenesis and protein synthesis. Nat Rev Cancer. 2010;10:301\u20139. https:\/\/doi.org\/10.1038\/nrc2819. [cited 2026 Mar 29].","journal-title":"Nat Rev Cancer"},{"key":"2749_CR8","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1016\/j.febslet.2014.04.014","volume":"588","author":"L Golomb","year":"2014","unstructured":"Golomb L, Volarevic S, Oren M. p53 and ribosome biogenesis stress: the essentials. FEBS Lett. 2014;588:2571\u20139. https:\/\/doi.org\/10.1016\/j.febslet.2014.04.014. [cited 2026 Mar 29].","journal-title":"FEBS Lett"},{"key":"2749_CR9","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s13045-018-0609-1","volume":"11","author":"E Derenzini","year":"2018","unstructured":"Derenzini E, Rossi A, Trer\u00e9 D. Treating hematological malignancies with drugs inhibiting ribosome biogenesis: when and why. J Hematol Oncol. 2018;11:75. https:\/\/doi.org\/10.1186\/s13045-018-0609-1. [cited 2026 Mar 29].","journal-title":"J Hematol Oncol"},{"key":"2749_CR10","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.ccr.2012.05.019","volume":"22","author":"MJ Bywater","year":"2012","unstructured":"Bywater MJ, Poortinga G, Sanij E, Hein N, Peck A, Cullinane C, et al. Inhibition of RNA Polymerase I as a Therapeutic Strategy to Promote Cancer-Specific Activation of p53. Cancer Cell. 2012;22:51\u201365. https:\/\/doi.org\/10.1016\/j.ccr.2012.05.019. [cited 2026 Mar 29].","journal-title":"Cancer Cell"},{"key":"2749_CR11","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/nrc2824","volume":"10","author":"D Silvera","year":"2010","unstructured":"Silvera D, Formenti SC, Schneider RJ. Translational control in cancer. Nat Rev Cancer. 2010;10:254\u201366. https:\/\/doi.org\/10.1038\/nrc2824. [cited 2026 Mar 29].","journal-title":"Nat Rev Cancer"},{"key":"2749_CR12","doi-asserted-by":"publisher","first-page":"6175","DOI":"10.1073\/pnas.90.13.6175","volume":"90","author":"IB Rosenwald","year":"1993","unstructured":"Rosenwald IB, Rhoads DB, Callanan LD, Isselbacher KJ, Schmidt EV. Increased expression of eukaryotic translation initiation factors eIF-4E and eIF-2 alpha in response to growth induction by c-myc. Proc Natl Acad Sci U S A. 1993;90:6175\u20138. https:\/\/doi.org\/10.1073\/pnas.90.13.6175. [cited 2026 Mar 29].","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2749_CR13","unstructured":"Ly C, Arechiga A, Melo JV, Walsh CM, Ong TS. Bcr-Abl kinase modulates the translation regulators ribosomal protein S6 and 4E-BP1 in chronic myelogenous leukemia cells via the mammalian target of rapamycin - PubMed. Cancer Res. 2003;63:5716\u201322. https:\/\/pubmed.ncbi.nlm.nih.gov\/14522890\/. Accessed 29 Mar 2026. [cited 2026 Mar 29]."},{"key":"2749_CR14","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1038\/sj.onc.1209901","volume":"26","author":"S Prabhu","year":"2007","unstructured":"Prabhu S, Saadat D, Zhang M, Halbur L, Fruehauf JP, Ong ST. A novel mechanism for Bcr-Abl action: Bcr-Abl-mediated induction of the eIF4F translation initiation complex and mRNA translation. Oncogene. 2007;26:1188\u2013200. https:\/\/doi.org\/10.1038\/sj.onc.1209901. [cited 2026 Mar 29].","journal-title":"Oncogene"},{"key":"2749_CR15","doi-asserted-by":"publisher","first-page":"5326","DOI":"10.1158\/0008-5472.CAN-07-5876","volume":"68","author":"CJ Lin","year":"2008","unstructured":"Lin CJ, Cencic R, Mills JR, Robert F, Pelletier J. c-Myc and eIF4F are components of a feedforward loop that links transcription and translation. Cancer Res. 2008;68:5326\u201334. https:\/\/doi.org\/10.1158\/0008-5472.CAN-07-5876. [cited 2026 Mar 29].","journal-title":"Cancer Res"},{"key":"2749_CR16","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.ccr.2010.05.023","volume":"18","author":"QB She","year":"2010","unstructured":"She QB, Halilovic E, Ye Q, Zhen W, Shirasawa S, Sasazuki T, et al. 4E-BP1 Is a Key Effector of the Oncogenic Activation of the AKT and ERK Signaling Pathways that Integrates Their Function in Tumors. Cancer Cell. 2010;18:39\u201351. https:\/\/doi.org\/10.1016\/j.ccr.2010.05.023. [cited 2026 Mar 29].","journal-title":"Cancer Cell"},{"key":"2749_CR17","doi-asserted-by":"publisher","first-page":"13984","DOI":"10.1073\/pnas.1008136107","volume":"107","author":"T Ueda","year":"2010","unstructured":"Ueda T, Sasaki M, Elia AJ, Chio IIC, Hamada K, Fukunaga R, et al. Combined deficiency for MAP kinase-interacting kinase 1 and 2 (Mnk1 and Mnk2) delays tumor development. Proc Natl Acad Sci U S A. 2010;107:13984\u201390. https:\/\/doi.org\/10.1073\/pnas.1008136107. [cited 2026 Mar 29].","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2749_CR18","doi-asserted-by":"publisher","first-page":"9189","DOI":"10.18632\/oncotarget.3279","volume":"6","author":"A Nogami","year":"2015","unstructured":"Nogami A, Oshikawa G, Okada K, Fukutake S, Umezawa Y, Nagao T, et al. FLT3-ITD confers resistance to the PI3K\/Akt pathway inhibitors by protecting the mTOR\/4EBP1\/Mcl-1 pathway through STAT5 activation in acute myeloid leukemia. Oncotarget. 2015;6:9189. https:\/\/doi.org\/10.18632\/oncotarget.3279. [cited 2026 Mar 29].","journal-title":"Oncotarget"},{"key":"2749_CR19","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/s41568-019-0105-0","volume":"19","author":"A Aspesi","year":"2019","unstructured":"Aspesi A, Ellis SR. Rare ribosomopathies: insights into mechanisms of cancer. Nat Rev Cancer. 2019;19:228\u201338. https:\/\/doi.org\/10.1038\/s41568-019-0105-0. [cited 2026 Mar 29].","journal-title":"Nat Rev Cancer"},{"key":"2749_CR20","doi-asserted-by":"publisher","first-page":"3196","DOI":"10.1182\/blood-2009-10-178129","volume":"115","author":"A Narla","year":"2010","unstructured":"Narla A, Ebert BL. Ribosomopathies: human disorders of ribosome dysfunction. Blood Blood. 2010;115:3196\u2013205. https:\/\/doi.org\/10.1182\/blood-2009-10-178129. [cited 2026 Mar 29].","journal-title":"Blood Blood"},{"key":"2749_CR21","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1158\/2159-8290.CD-18-1455","volume":"9","author":"A Khot","year":"2019","unstructured":"Khot A, Brajanovski N, Cameron DP, Hein N, Maclachlan KH, Sanij E, et al. First-in-Human RNA Polymerase I Transcription Inhibitor CX-5461 in Patients with Advanced Hematologic Cancers: Results of a Phase I Dose-Escalation Study. Cancer Discov. 2019;9:1036\u201349. https:\/\/doi.org\/10.1158\/2159-8290.CD-18-1455. [cited 2026 Mar 29].","journal-title":"Cancer Discov"},{"key":"2749_CR22","doi-asserted-by":"publisher","first-page":"100202","DOI":"10.1016\/j.bneo.2026.100202","volume":"3","author":"YS Lee","year":"2026","unstructured":"Lee YS, Good JD, Awais N, Eschle BK, Lineberry MS, Lin J, et al. Synergistic targeting of eIF4A-mediated translation initiation and apoptosis in acute myeloid leukemia. Blood Neoplasia. 2026;3:100202. https:\/\/doi.org\/10.1016\/j.bneo.2026.100202. [cited 2026 Mar 29].","journal-title":"Blood Neoplasia"},{"key":"2749_CR23","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/S0968-0004(99)01460-7","volume":"24","author":"JR Warner","year":"1999","unstructured":"Warner JR. The economics of ribosome biosynthesis in yeast. Trends Biochem Sci. 1999;24:437\u201340. https:\/\/doi.org\/10.1016\/S0968-0004(99)01460-7. [cited 2026 Mar 30].","journal-title":"Trends Biochem Sci"},{"key":"2749_CR24","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/nrc.2017.104","volume":"18","author":"J Pelletier","year":"2018","unstructured":"Pelletier J, Thomas G, Volarevi S. Ribosome biogenesis in cancer: new players and therapeutic avenues. Nat Rev Cancer. 2018;18:51\u201363. https:\/\/doi.org\/10.1038\/nrc.2017.104. [cited 2026 Mar 30].","journal-title":"Nat Rev Cancer"},{"key":"2749_CR25","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.trecan.2020.08.003","volume":"7","author":"S Bursa\u0107","year":"2021","unstructured":"Bursa\u0107 S, Prodan Y, Pullen N, Bartek J, Volarevi\u0107 S. Dysregulated Ribosome Biogenesis Reveals Therapeutic Liabilities in Cancer. Trends Cancer. 2021;7:57\u201376. https:\/\/doi.org\/10.1016\/j.trecan.2020.08.003. [cited 2026 Mar 30].","journal-title":"Trends Cancer"},{"key":"2749_CR26","doi-asserted-by":"publisher","first-page":"29551","DOI":"10.1074\/jbc.M501595200","volume":"280","author":"JK Friedrich","year":"2005","unstructured":"Friedrich JK, Panov KI, Cabart P, Russell J, Zomerdijk JCBM. TBP-TAF complex SL1 directs RNA polymerase I pre-initiation complex formation and stabilizes upstream binding factor at the rDNA promoter. J Biol Chem. 2005;280:29551\u20138. https:\/\/doi.org\/10.1074\/jbc.M501595200. [cited 2026 Mar 30].","journal-title":"J Biol Chem"},{"key":"2749_CR27","doi-asserted-by":"publisher","first-page":"3310","DOI":"10.1038\/sj.emboj.7601221","volume":"25","author":"KI Panov","year":"2006","unstructured":"Panov KI, Friedrich JK, Russell J, Zomerdijk JCBM. UBF activates RNA polymerase I transcription by stimulating promoter escape. EMBO J. 2006;25:3310\u201322. https:\/\/doi.org\/10.1038\/sj.emboj.7601221. [cited 2026 Mar 30].","journal-title":"EMBO J"},{"key":"2749_CR28","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/ncb1225","volume":"7","author":"A Arabi","year":"2005","unstructured":"Arabi A, Wu S, Ridderstr\u00e5le K, Bierhoff H, Shiue C, Fatyol K, et al. c-Myc associates with ribosomal DNA and activates RNA polymerase I transcription. Nat Cell Biol. 2005;7:303\u201310. https:\/\/doi.org\/10.1038\/ncb1225. [cited 2026 Mar 30].","journal-title":"Nat Cell Biol"},{"key":"2749_CR29","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/ncb1224","volume":"7","author":"C Grandori","year":"2005","unstructured":"Grandori C, Gomez-Roman N, Felton-Edkins ZA, Ngouenet C, Galloway DA, Eisenman RN, et al. c-Myc binds to human ribosomal DNA and stimulates transcription of rRNA genes by RNA polymerase I. Nat Cell Biol. 2005;7:311\u20138. https:\/\/doi.org\/10.1038\/ncb1224. [cited 2026 Mar 30].","journal-title":"Nat Cell Biol"},{"key":"2749_CR30","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1038\/s41556-024-01420-z","volume":"26","author":"L Yang","year":"2024","unstructured":"Yang L, Zhang Z, Jiang P, Kong D, Yu Z, Shi D, et al. Phase separation-competent FBL promotes early pre-rRNA processing and translation in acute myeloid leukaemia. Nat Cell Biol. 2024;26:946\u201361. https:\/\/doi.org\/10.1038\/s41556-024-01420-z. [cited 2026 Mar 30].","journal-title":"Nat Cell Biol"},{"key":"2749_CR31","doi-asserted-by":"publisher","first-page":"3008","DOI":"10.1016\/J.MOLCEL.2024.07.029","volume":"84","author":"A Dabrowska","year":"2024","unstructured":"Dabrowska A, Ruggero D. snoRNAs in making snoman ribosomes. Mol Cell. 2024;84:3008\u201310. https:\/\/doi.org\/10.1016\/J.MOLCEL.2024.07.029. [cited 2026 Apr 12].","journal-title":"Mol Cell"},{"key":"2749_CR32","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1126\/SCIENCE.1252651","volume":"344","author":"D Larrieu","year":"2014","unstructured":"Larrieu D, Britton S, Demir M, Rodriguez R, Jackson SP. Chemical inhibition of NAT10 corrects defects of laminopathic cells. Science. 2014;344:527\u201332. https:\/\/doi.org\/10.1126\/SCIENCE.1252651. [cited 2026 Apr 6].","journal-title":"Science"},{"key":"2749_CR33","doi-asserted-by":"publisher","first-page":"e511","DOI":"10.1016\/S2352-3026(20)30120-4","volume":"7","author":"N Kalakonda","year":"2020","unstructured":"Kalakonda N, Maerevoet M, Cavallo F, Follows G, Goy A, Vermaat JSP, et al. Selinexor in patients with relapsed or refractory diffuse large B-cell lymphoma (SADAL): a single-arm, multinational, multicentre, open-label, phase 2 trial. Lancet Haematol. 2020;7:e511\u201322. https:\/\/doi.org\/10.1016\/S2352-3026(20)30120-4. [cited 2026 Jun 29].","journal-title":"Lancet Haematol"},{"key":"2749_CR34","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1056\/NEJMOA1903455","volume":"381","author":"A Chari","year":"2019","unstructured":"Chari A, Vogl DT, Gavriatopoulou M, Nooka AK, Yee AJ, Huff CA, et al. Oral Selinexor-Dexamethasone for Triple-Class Refractory Multiple Myeloma. N Engl J Med. 2019;381:727\u201338. https:\/\/doi.org\/10.1056\/NEJMOA1903455. [cited 2026 Jun 29].","journal-title":"N Engl J Med"},{"key":"2749_CR35","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1101\/gad.623011","volume":"25","author":"AJ Finch","year":"2011","unstructured":"Finch AJ, Hilcenko C, Basse N, Drynan LF, Goyenechea B, Menne TF, et al. Uncoupling of GTP hydrolysis from eIF6 release on the ribosome causes Shwachman-Diamond syndrome. Genes Dev. 2011;25:917\u201329. https:\/\/doi.org\/10.1101\/gad.623011. [cited 2026 Mar 30].","journal-title":"Genes Dev"},{"key":"2749_CR36","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.jbior.2017.09.002","volume":"67","author":"AJ Warren","year":"2018","unstructured":"Warren AJ. Molecular basis of the human ribosomopathy Shwachman-Diamond syndrome. Adv Biol Regul. 2018;67:109\u201327. https:\/\/doi.org\/10.1016\/j.jbior.2017.09.002. [cited 2026 Mar 30].","journal-title":"Adv Biol Regul"},{"key":"2749_CR37","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.cell.2009.01.042","volume":"136","author":"N Sonenberg","year":"2009","unstructured":"Sonenberg N, Hinnebusch AG. Regulation of translation initiation in eukaryotes: mechanisms and biological targets. Cell. 2009;136:731\u201345. https:\/\/doi.org\/10.1016\/j.cell.2009.01.042. [cited 2026 Mar 30].","journal-title":"Cell"},{"key":"2749_CR38","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/nrm2838","volume":"11","author":"RJ Jackson","year":"2010","unstructured":"Jackson RJ, Hellen CUT, Pestova TV. The mechanism of eukaryotic translation initiation and principles of its regulation. Nat Rev Mol Cell Biol. 2010;11:113\u201327. https:\/\/doi.org\/10.1038\/nrm2838. [cited 2026 Mar 30].","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2749_CR39","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1101\/gad.1262905","volume":"19","author":"A Kahvejian","year":"2005","unstructured":"Kahvejian A, Svitkin YV, Sukarieh R, M\u2019Boutchou MN, Sonenberg N. Mammalian poly(A)-binding protein is a eukaryotic translation initiation factor, which acts via multiple mechanisms. Genes Dev. 2005;19:104\u201313. https:\/\/doi.org\/10.1101\/gad.1262905. [cited 2026 Mar 30].","journal-title":"Genes Dev"},{"key":"2749_CR40","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/s41594-023-01196-0","volume":"31","author":"J Brito Querido","year":"2024","unstructured":"Brito Querido J, Sokabe M, D\u00edaz-L\u00f3pez I, Gordiyenko Y, Fraser CS, Ramakrishnan V. The structure of a human translation initiation complex reveals two independent roles for the helicase eIF4A. Nat Struct Mol Biol. 2024;31:455\u201364. https:\/\/doi.org\/10.1038\/s41594-023-01196-0. [cited 2026 Mar 30].","journal-title":"Nat Struct Mol Biol"},{"key":"2749_CR41","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1101\/gad.13.11.1422","volume":"13","author":"AC Gingras","year":"1999","unstructured":"Gingras AC, Gygi SP, Raught B, Polakiewicz RD, Abraham RT, Hoekstra MF, et al. Regulation of 4E-BP1 phosphorylation: a novel two-step mechanism. Genes Dev. 1999;13:1422\u201337. https:\/\/doi.org\/10.1101\/gad.13.11.1422. [cited 2026 Mar 30].","journal-title":"Genes Dev"},{"key":"2749_CR42","doi-asserted-by":"publisher","first-page":"6539","DOI":"10.1128\/mcb.24.15.6539-6549.2004","volume":"24","author":"T Ueda","year":"2004","unstructured":"Ueda T, Watanabe-Fukunaga R, Fukuyama H, Nagata S, Fukunaga R. Mnk2 and Mnk1 are essential for constitutive and inducible phosphorylation of eukaryotic initiation factor 4E but not for cell growth or development. Mol Cell Biol. 2004;24:6539\u201349. https:\/\/doi.org\/10.1128\/mcb.24.15.6539-6549.2004. [cited 2026 Mar 30].","journal-title":"Mol Cell Biol"},{"key":"2749_CR43","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/nrm2672","volume":"10","author":"XM Ma","year":"2009","unstructured":"Ma XM, Blenis J. Molecular mechanisms of mTOR-mediated translational control. Nat Rev Mol Cell Biol. 2009;10:307\u201318. https:\/\/doi.org\/10.1038\/nrm2672. [cited 2026 Mar 30].","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2749_CR44","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/nrm3025","volume":"12","author":"R Zoncu","year":"2011","unstructured":"Zoncu R, Efeyan A, Sabatini DM. mTOR: from growth signal integration to cancer, diabetes and ageing. Nat Rev Mol Cell Biol. 2011;12:21\u201335. https:\/\/doi.org\/10.1038\/nrm3025. [cited 2026 Mar 30].","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2749_CR45","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1126\/science.1130276","volume":"314","author":"NV Dorrello","year":"2006","unstructured":"Dorrello NV, Peschiaroli A, Guardavaccaro D, Colburn NH, Sherman NE, Pagano M. S6K1- and betaTRCP-mediated degradation of PDCD4 promotes protein translation and cell growth. Science. 2006;314:467\u201371. https:\/\/doi.org\/10.1126\/science.1130276. [cited 2026 Mar 30].","journal-title":"Science"},{"key":"2749_CR46","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/nature11083","volume":"485","author":"CC Thoreen","year":"2012","unstructured":"Thoreen CC, Chantranupong L, Keys HR, Wang T, Gray NS, Sabatini DM. A unifying model for mTORC1-mediated regulation of mRNA translation. Nature. 2012;485:109\u201313. https:\/\/doi.org\/10.1038\/nature11083. [cited 2026 Mar 30].","journal-title":"Nature"},{"key":"2749_CR47","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nature10912","volume":"485","author":"AC Hsieh","year":"2012","unstructured":"Hsieh AC, Liu Y, Edlind MP, Ingolia NT, Janes MR, Sher A, et al. The translational landscape of mTOR signalling steers cancer initiation and metastasis. Nature. 2012;485:55\u201361. https:\/\/doi.org\/10.1038\/nature10912. [cited 2026 Mar 30].","journal-title":"Nature"},{"key":"2749_CR48","doi-asserted-by":"publisher","unstructured":"Lahr RM, Fonseca BD, Ciotti GE, Al-Ashtal HA, Jia JJ, Niklaus MR, et al. La-related protein 1 (LARP1) binds the mRNA cap, blocking eIF4F assembly on TOP mRNAs. Elife. 2017;6. https:\/\/doi.org\/10.7554\/eLife.24146. [cited 2026 Mar 30].","DOI":"10.7554\/eLife.24146"},{"key":"2749_CR49","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/nature13485","volume":"513","author":"AL Wolfe","year":"2014","unstructured":"Wolfe AL, Singh K, Zhong Y, Drewe P, Rajasekhar VK, Sanghvi VR, et al. RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer. Nature. 2014;513:65\u201370. https:\/\/doi.org\/10.1038\/nature13485. [cited 2026 Mar 30].","journal-title":"Nature"},{"key":"2749_CR50","doi-asserted-by":"publisher","unstructured":"Modelska A, Turro E, Russell R, Beaton J, Sbarrato T, Spriggs K, et al. The malignant phenotype in breast cancer is driven by eIF4A1-mediated changes in the translational landscape. Cell Death Dis. 2015;6. https:\/\/doi.org\/10.1038\/cddis.2014.542. [cited 2026 Mar 30].","DOI":"10.1038\/cddis.2014.542"},{"key":"2749_CR51","doi-asserted-by":"publisher","first-page":"11269","DOI":"10.1073\/pnas.0400541101","volume":"101","author":"KM Vattem","year":"2004","unstructured":"Vattem KM, Wek RC. Reinitiation involving upstream ORFs regulates ATF4 mRNA translation in mammalian cells. Proc Natl Acad Sci U S A. 2004;101:11269\u201374. https:\/\/doi.org\/10.1073\/pnas.0400541101. [cited 2026 Mar 30].","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2749_CR52","doi-asserted-by":"publisher","first-page":"229","DOI":"10.4161\/cc.10.2.14472","volume":"10","author":"AA Komar","year":"2011","unstructured":"Komar AA, Hatzoglou M. Cellular IRES-mediated translation: the war of ITAFs in pathophysiological states. Cell Cycle. 2011;10:229\u201340. https:\/\/doi.org\/10.4161\/cc.10.2.14472. [cited 2026 Mar 30].","journal-title":"Cell Cycle"},{"key":"2749_CR53","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/nature24678","volume":"552","author":"I Barbieri","year":"2017","unstructured":"Barbieri I, Tzelepis K, Pandolfini L, Shi J, Mill\u00e1n-Zambrano G, Robson SC, et al. Promoter-bound METTL3 maintains myeloid leukaemia by m6A-dependent translation control. Nature. 2017;552:126\u201331. https:\/\/doi.org\/10.1038\/nature24678. [cited 2026 Mar 30].","journal-title":"Nature"},{"key":"2749_CR54","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/j.cell.2015.10.012","volume":"163","author":"KD Meyer","year":"2015","unstructured":"Meyer KD, Patil DP, Zhou J, Zinoviev A, Skabkin MA, Elemento O, et al. 5\u2032 UTR m6A Promotes Cap-Independent Translation. Cell. 2015;163:999\u20131010. https:\/\/doi.org\/10.1016\/j.cell.2015.10.012. [cited 2026 Apr 28].","journal-title":"Cell"},{"key":"2749_CR55","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.molcel.2017.10.002","volume":"68","author":"RA Coots","year":"2017","unstructured":"Coots RA, Liu XM, Mao Y, Dong L, Zhou J, Wan J, et al. m6A Facilitates eIF4F-Independent mRNA Translation. Mol Cell. 2017;68:504\u201314.e7. https:\/\/doi.org\/10.1016\/j.molcel.2017.10.002. [cited 2026 Apr 28].\u00a0","journal-title":"Mol Cell"},{"key":"2749_CR56","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1002\/PRO.3190","volume":"26","author":"A Prabhakar","year":"2017","unstructured":"Prabhakar A, Choi J, Wang J, Petrov A, Puglisi JD. Dynamic basis of fidelity and speed in translation: Coordinated multistep mechanisms of elongation and termination. Protein Sci. 2017;26:1352\u201362. https:\/\/doi.org\/10.1002\/PRO.3190. [cited 2026 Jun 30].","journal-title":"Protein Sci"},{"key":"2749_CR57","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/j.cell.2013.04.055","volume":"153","author":"G Leprivier","year":"2013","unstructured":"Leprivier G, Remke M, Rotblat B, Dubuc A, Mateo ARF, Kool M, et al. The eEF2 kinase confers resistance to nutrient deprivation by blocking translation elongation. Cell. 2013;153:1064. https:\/\/doi.org\/10.1016\/j.cell.2013.04.055. [cited 2026 Mar 30].","journal-title":"Cell"},{"key":"2749_CR58","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.semcancer.2022.04.006","volume":"86","author":"A Rubio","year":"2022","unstructured":"Rubio A, Garland GD, Sfakianos A, Harvey RF, Willis AE. Aberrant protein synthesis and cancer development: The role of canonical eukaryotic initiation, elongation and termination factors in tumorigenesis. Semin Cancer Biol. 2022;86:151\u201365. https:\/\/doi.org\/10.1016\/j.semcancer.2022.04.006. [cited 2026 Mar 30].","journal-title":"Semin Cancer Biol"},{"key":"2749_CR59","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/s41586-021-04131-9","volume":"600","author":"M Djumagulov","year":"2021","unstructured":"Djumagulov M, Demeshkina N, Jenner L, Rozov A, Yusupov M, Yusupova G. Accuracy mechanism of eukaryotic ribosome translocation. Nature. 2021;600:543\u20136. https:\/\/doi.org\/10.1038\/s41586-021-04131-9. [cited 2026 Mar 30].","journal-title":"Nature"},{"key":"2749_CR60","doi-asserted-by":"publisher","first-page":"4370","DOI":"10.1093\/emboj\/20.16.4370","volume":"20","author":"X Wang","year":"2001","unstructured":"Wang X, Li W, Williams M, Terada N, Alessi DR, Proud CG. Regulation of elongation factor 2 kinase by p90(RSK1) and p70 S6 kinase. EMBO J. 2001;20:4370\u20139. https:\/\/doi.org\/10.1093\/emboj\/20.16.4370. [cited 2026 Mar 30].","journal-title":"EMBO J"},{"key":"2749_CR61","doi-asserted-by":"publisher","unstructured":"Gkatza NA, Castro C, Harvey RF, Hei\u00df M, Popis MC, Blanco S, et al. Cytosine-5 RNA methylation links protein synthesis to cell metabolism. PLoS Biol. 2019;17. https:\/\/doi.org\/10.1371\/journal.pbio.3000297. [cited 2026 Mar 30].","DOI":"10.1371\/journal.pbio.3000297"},{"key":"2749_CR62","doi-asserted-by":"publisher","first-page":"3323","DOI":"10.1016\/j.molcel.2021.06.031","volume":"81","author":"EA Orellana","year":"2021","unstructured":"Orellana EA, Liu Q, Yankova E, Pirouz M, De Braekeleer E, Zhang W, et al. METTL1-mediated m7G modification of Arg-TCT tRNA drives oncogenic transformation. Mol Cell. 2021;81:3323\u2013e333814. https:\/\/doi.org\/10.1016\/j.molcel.2021.06.031. [cited 2026 Mar 30].","journal-title":"Mol Cell"},{"key":"2749_CR63","doi-asserted-by":"publisher","first-page":"301","DOI":"10.2353\/ajpath.2008.070752","volume":"173","author":"L Montanaro","year":"2008","unstructured":"Montanaro L, Trer\u00e9 D, Derenzini M. Nucleolus, ribosomes, and cancer. Am J Pathol. 2008;173:301\u201310. https:\/\/doi.org\/10.2353\/ajpath.2008.070752. [cited 2026 Jun 29].","journal-title":"Am J Pathol"},{"key":"2749_CR64","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1111\/bjh.14525","volume":"177","author":"HC Lee","year":"2017","unstructured":"Lee HC, Wang H, Baladandayuthapani V, Lin H, He J, Jones RJ, et al. RNA Polymerase I Inhibition with CX-5461 as a Novel Therapeutic Strategy to Target MYC in Multiple Myeloma. Br J Haematol. 2017;177:80\u201394. https:\/\/doi.org\/10.1111\/bjh.14525. [cited 2026 Mar 30].","journal-title":"Br J Haematol"},{"key":"2749_CR65","doi-asserted-by":"publisher","first-page":"2882","DOI":"10.1182\/blood-2016-05-718171","volume":"129","author":"N Hein","year":"2017","unstructured":"Hein N, Cameron DP, Hannan KM, Nguyen NYN, Fong CY, Sornkom J, et al. Inhibition of Pol I transcription treats murine and human AML by targeting the leukemia-initiating cell population. Blood. 2017;129:2882\u201395. https:\/\/doi.org\/10.1182\/blood-2016-05-718171. [cited 2026 Mar 30].","journal-title":"Blood"},{"key":"2749_CR66","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.ccr.2009.09.024","volume":"16","author":"Y Zhang","year":"2009","unstructured":"Zhang Y, Lu H. Signaling to p53: Ribosomal Proteins Find Their Way. Cancer Cell. 2009;16:369\u201377. https:\/\/doi.org\/10.1016\/j.ccr.2009.09.024. [cited 2026 Mar 30].","journal-title":"Cancer Cell"},{"key":"2749_CR67","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.ccr.2010.08.0070","volume":"18","author":"E Macias","year":"2010","unstructured":"Macias E, Jin A, Deisenroth C, Bhat K, Mao H, Lindstr\u00f6m MS, et al. An ARF-Independent c-MYC-activated tumor suppression pathway mediated by ribosomal protein-Mdm2 interaction. Cancer Cell. 2010;18:231\u201343. https:\/\/doi.org\/10.1016\/j.ccr.2010.08.0070. [cited 2026 Mar 30].","journal-title":"Cancer Cell"},{"key":"2749_CR68","doi-asserted-by":"publisher","first-page":"5030","DOI":"10.1158\/0008-5472.CAN-15-3420","volume":"76","author":"X Meng","year":"2016","unstructured":"Meng X, Tackmann NR, Liu S, Yang J, Dong J, Wu C, et al. RPL23 Links Oncogenic RAS Signaling to p53-Mediated Tumor Suppression. Cancer Res. 2016;76:5030\u20139. https:\/\/doi.org\/10.1158\/0008-5472.CAN-15-3420. [cited 2026 Jun 29].","journal-title":"Cancer Res"},{"key":"2749_CR69","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.celrep.2013.08.049","volume":"5","author":"KE Sloan","year":"2013","unstructured":"Sloan KE, Bohnsack MT, Watkins NJ. The 5S RNP Couples p53 Homeostasis to Ribosome Biogenesis and Nucleolar Stress. Cell Rep. 2013;5:237\u201347. https:\/\/doi.org\/10.1016\/j.celrep.2013.08.049. [cited 2026 Mar 30].","journal-title":"Cell Rep"},{"key":"2749_CR70","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1038\/s41594-023-01006-7","volume":"30","author":"NM de Castillo Duque","year":"2023","unstructured":"de Castillo Duque NM, Thoms M, Flemming D, Hammaren HM, Buschauer R, Ameismeier M, et al. Structure of nascent 5S RNPs at the crossroad between ribosome assembly and MDM2-p53 pathways. Nat Struct Mol Biol. 2023;30:1119\u201331. https:\/\/doi.org\/10.1038\/s41594-023-01006-7. [cited 2026 Mar 30].","journal-title":"Nat Struct Mol Biol"},{"key":"2749_CR71","doi-asserted-by":"publisher","first-page":"49800","DOI":"10.18632\/oncotarget.10452","volume":"7","author":"J Quin","year":"2016","unstructured":"Quin J, Chan KT, Devlin JR, Cameron DP, Diesch J, Cullinane C, et al. Inhibition of RNA polymerase I transcription initiation by CX-5461 activates non-canonical ATM\/ATR signaling. Oncotarget. 2016;7:49800\u201318. https:\/\/doi.org\/10.18632\/oncotarget.10452. [cited 2026 Mar 30].","journal-title":"Oncotarget"},{"key":"2749_CR72","doi-asserted-by":"publisher","unstructured":"Xu H, Di Antonio M, McKinney S, Mathew V, Ho B, O\u2019Neil NJ, et al. CX-5461 is a DNA G-quadruplex stabilizer with selective lethality in BRCA1\/2 deficient tumours. Nat Commun. 2017;8. https:\/\/doi.org\/10.1038\/ncomms14432. [cited 2026 Mar 30].","DOI":"10.1038\/ncomms14432"},{"key":"2749_CR73","doi-asserted-by":"publisher","first-page":"4053","DOI":"10.1073\/pnas.1921649117","volume":"117","author":"PM Bruno","year":"2020","unstructured":"Bruno PM, Lu M, Dennis KA, Inam H, Moore CJ, Sheehe J, et al. The primary mechanism of cytotoxicity of the chemotherapeutic agent CX-5461 is topoisomerase II poisoning. Proc Natl Acad Sci U S A. 2020;117:4053\u201360. https:\/\/doi.org\/10.1073\/pnas.1921649117. [cited 2026 Mar 30].","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2749_CR74","doi-asserted-by":"publisher","unstructured":"Sanij E, Hannan KM, Xuan J, Yan S, Ahern JE, Trigos AS, et al. CX-5461 activates the DNA damage response and demonstrates therapeutic efficacy in high-grade serous ovarian cancer. Nat Commun. 2020;11. https:\/\/doi.org\/10.1038\/s41467-020-16393-4. [cited 2026 Mar 31].","DOI":"10.1038\/s41467-020-16393-4"},{"key":"2749_CR75","doi-asserted-by":"publisher","unstructured":"Cameron DP, Sornkom J, Alsahafi S, Drygin D, Poortinga G, McArthur GA, et al. CX-5461 Preferentially Induces Top2\u03b1-Dependent DNA Breaks at Ribosomal DNA Loci. Biomedicines. 2024;12. https:\/\/doi.org\/10.3390\/biomedicines12071514. [cited 2026 Mar 30].","DOI":"10.3390\/biomedicines12071514"},{"key":"2749_CR76","doi-asserted-by":"publisher","DOI":"10.1101\/2025.04.19.649466","author":"R Ferreira","year":"2025","unstructured":"Ferreira R, Hannan KM, Panov K, Udumanne T, George AJ, Closa A, et al. The novel RNA polymerase I transcription inhibitor PMR-116 exploits a critical therapeutic vulnerability in a broad-spectrum of high MYC malignancies. bioRxiv. Cold Spring Harbor Lab. 2025. https:\/\/doi.org\/10.1101\/2025.04.19.649466. [cited 2026 Jun 29]. 2025.04.19.649466.","journal-title":"Cold Spring Harbor Lab"},{"key":"2749_CR77","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1056\/nejmoa041974","volume":"352","author":"B Falini","year":"2005","unstructured":"Falini B, Mecucci C, Tiacci E, Alcalay M, Rosati R, Pasqualucci L, et al. Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype. N Engl J Med. 2005;352:254\u201366. https:\/\/doi.org\/10.1056\/nejmoa041974. [cited 2026 Mar 30].","journal-title":"N Engl J Med"},{"key":"2749_CR78","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1002\/ajh.26989","volume":"98","author":"B Falini","year":"2023","unstructured":"Falini B. NPM1-mutated acute myeloid leukemia: New pathogenetic and therapeutic insights and open questions. Am J Hematol. 2023;98:1452\u201364. https:\/\/doi.org\/10.1002\/ajh.26989. [cited 2026 Mar 30].","journal-title":"Am J Hematol"},{"key":"2749_CR79","doi-asserted-by":"publisher","unstructured":"Lindstr\u00f6m MS. NPM1\/B23: A Multifunctional Chaperone in Ribosome Biogenesis and Chromatin Remodeling. Biochem Res Int. 2011;2011. https:\/\/doi.org\/10.1155\/2011\/195209. [cited 2026 Mar 30].","DOI":"10.1155\/2011\/195209"},{"key":"2749_CR80","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1002\/JHA2.996","volume":"5","author":"L Brunetti","year":"2024","unstructured":"Brunetti L, Pianigiani G, Gundry MC, Goodell MA, Falini B. Mutant NPM1 marginally impacts ribosome footprint in acute myeloid leukemia cells. EJHaem. 2024;5:1028. https:\/\/doi.org\/10.1002\/JHA2.996. [cited 2026 Apr 28].","journal-title":"EJHaem"},{"key":"2749_CR81","doi-asserted-by":"publisher","first-page":"4028","DOI":"10.1182\/BLOODADVANCES.2022007420","volume":"6","author":"I Khan","year":"2022","unstructured":"Khan I, Gartel AL. The antagonistic duality of NPM1 mutations in AML. Blood Adv Am Soc Hematol. 2022;6:4028. https:\/\/doi.org\/10.1182\/BLOODADVANCES.2022007420. [cited 2026 Apr 28].","journal-title":"Blood Adv Am Soc Hematol"},{"key":"2749_CR82","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1182\/BLOOD.2024026113","volume":"146","author":"A Damaskou","year":"2025","unstructured":"Damaskou A, Wilson R, Gozdecka M, Giotopoulos G, Asby R, Eleftheriou M, et al. Posttranscriptional depletion of ribosome biogenesis factors engenders therapeutic vulnerabilities in NPM1-mutant AML. Blood. 2025;146:1239\u201352. https:\/\/doi.org\/10.1182\/BLOOD.2024026113. [cited 2026 Apr 28].","journal-title":"Blood"},{"key":"2749_CR83","doi-asserted-by":"publisher","first-page":"6148","DOI":"10.1093\/nar\/gkg794","volume":"31","author":"I Schlosser","year":"2003","unstructured":"Schlosser I, H\u00f6lzel M, M\u00fcrnseer M, Burtscher H, Weidle UH, Eick D. A role for c-Myc in the regulation of ribosomal RNA processing. Nucleic Acids Res. 2003;31:6148\u201356. https:\/\/doi.org\/10.1093\/nar\/gkg794. [cited 2026 Mar 30].","journal-title":"Nucleic Acids Res"},{"key":"2749_CR84","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1038\/nature07449","volume":"456","author":"M Barna","year":"2008","unstructured":"Barna M, Pusic A, Zollo O, Costa M, Kondrashov N, Rego E, et al. Suppression of Myc oncogenic activity by ribosomal protein haploinsufficiency. Nature. 2008;456:971\u20135. https:\/\/doi.org\/10.1038\/nature07449. [cited 2026 Mar 30].","journal-title":"Nature"},{"key":"2749_CR85","doi-asserted-by":"publisher","first-page":"11988","DOI":"10.1073\/pnas.1310230110","volume":"110","author":"M Pourdehnad","year":"2013","unstructured":"Pourdehnad M, Truitt ML, Siddiqi IN, Ducker GS, Shokat KM, Ruggero D. Myc and mTOR converge on a common node in protein synthesis control that confers synthetic lethality in Myc-driven cancers. Proc Natl Acad Sci U S A. 2013;110:11988\u201393. https:\/\/doi.org\/10.1073\/pnas.1310230110. [cited 2026 Mar 30].","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2749_CR86","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.ccr.2010.01.021","volume":"17","author":"AC Hsieh","year":"2010","unstructured":"Hsieh AC, Costa M, Zollo O, Davis C, Feldman ME, Testa JR, et al. Genetic Dissection of the Oncogenic mTOR Pathway Reveals Druggable Addiction to Translational Control via 4EBP-eIF4E. Cancer Cell. 2010;17:249\u201361. https:\/\/doi.org\/10.1016\/j.ccr.2010.01.021. [cited 2026 Mar 31].","journal-title":"Cancer Cell"},{"key":"2749_CR87","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/251385a0","volume":"251","author":"HF Lodish","year":"1974","unstructured":"Lodish HF. Model for the regulation of mRNA translation applied to haemoglobin synthesis. Nature. 1974;251:385\u20138. https:\/\/doi.org\/10.1038\/251385a0. [cited 2026 Mar 31].","journal-title":"Nature"},{"key":"2749_CR88","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1158\/0008-5472.CAN-16-1298","volume":"77","author":"CE Joyce","year":"2017","unstructured":"Joyce CE, Yanez AG, Mori A, Yoda A, Carroll JS, Novina CD. Differential Regulation of the Melanoma Proteome by eIF4A1 and eIF4E. Cancer Res. 2017;77:613\u201322. https:\/\/doi.org\/10.1158\/0008-5472.CAN-16-1298. [cited 2026 Mar 31].","journal-title":"Cancer Res"},{"key":"2749_CR89","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.cell.2015.05.049","volume":"162","author":"ML Truitt","year":"2015","unstructured":"Truitt ML, Conn CS, Shi Z, Pang X, Tokuyasu T, Coady AM, et al. Differential Requirements for eIF4E Dose in Normal Development and Cancer. Cell. 2015;162:59\u201371. https:\/\/doi.org\/10.1016\/j.cell.2015.05.049. [cited 2026 Mar 31].","journal-title":"Cell"},{"key":"2749_CR90","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/j.molcel.2018.11.026","volume":"73","author":"S Iwasaki","year":"2019","unstructured":"Iwasaki S, Iwasaki W, Takahashi M, Sakamoto A, Watanabe C, Shichino Y, et al. The Translation Inhibitor Rocaglamide Targets a Bimolecular Cavity between eIF4A and Polypurine RNA. Mol Cell. 2019;73:738\u2013e7489. https:\/\/doi.org\/10.1016\/j.molcel.2018.11.026. [cited 2026 Mar 31].","journal-title":"Mol Cell"},{"key":"2749_CR91","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/nature17978","volume":"534","author":"S Iwasaki","year":"2016","unstructured":"Iwasaki S, Floor SN, Ingolia NT. Rocaglates convert DEAD-box protein eIF4A into a sequence-selective translational repressor. Nature. 2016;534:558\u201361. https:\/\/doi.org\/10.1038\/nature17978. [cited 2026 Mar 31].","journal-title":"Nature"},{"key":"2749_CR92","doi-asserted-by":"publisher","first-page":"5879","DOI":"10.1021\/acs.jmedchem.0c00182","volume":"63","author":"JT Ernst","year":"2020","unstructured":"Ernst JT, Thompson PA, Nilewski C, Sprengeler PA, Sperry S, Packard G, et al. Design of Development Candidate eFT226, a First in Class Inhibitor of Eukaryotic Initiation Factor 4A RNA Helicase. J Med Chem. 2020;63:5879\u2013955. https:\/\/doi.org\/10.1021\/acs.jmedchem.0c00182. [cited 2026 Mar 31].","journal-title":"J Med Chem"},{"key":"2749_CR93","doi-asserted-by":"publisher","unstructured":"Gerson-Gurwitz A, Young NP, Goel VK, Eam B, Stumpf CR, Chen J, et al. Zotatifin, an eIF4A-selective inhibitor, blocks tumor growth in receptor tyrosine kinase driven tumors. Front Oncol. 2021;11. https:\/\/doi.org\/10.3389\/fonc.2021.766298. [cited 2026 Mar 31].","DOI":"10.3389\/fonc.2021.766298"},{"key":"2749_CR94","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1158\/1535-7163.MCT-19-0973","volume":"20","author":"PA Thompson","year":"2021","unstructured":"Thompson PA, Eam B, Young NP, Fish S, Chen J, Barrera M, et al. Targeting Oncogene mRNA Translation in B-Cell Malignancies with eFT226, a Potent and Selective Inhibitor of eIF4A. Mol Cancer Ther. 2021;20:26\u201336. https:\/\/doi.org\/10.1158\/1535-7163.MCT-19-0973. [cited 2026 Mar 31].","journal-title":"Mol Cancer Ther"},{"key":"2749_CR95","doi-asserted-by":"publisher","first-page":"6337","DOI":"10.1007\/s00018-021-03910-x","volume":"78","author":"S Wilmore","year":"2021","unstructured":"Wilmore S, Rogers-Broadway KR, Taylor J, Lemm E, Fell R, Stevenson FK, et al. Targeted inhibition of eIF4A suppresses B-cell receptor-induced translation and expression of MYC and MCL1 in chronic lymphocytic leukemia cells. Cell Mol Life Sci. 2021;78:6337\u201349. https:\/\/doi.org\/10.1007\/s00018-021-03910-x. [cited 2026 Mar 31].","journal-title":"Cell Mol Life Sci"},{"key":"2749_CR96","doi-asserted-by":"publisher","unstructured":"Fooks K, Galicia-Vazquez G, Gife V, Schcolnik-Cabrera A, Nouhi Z, Poon WWL, et al. EIF4A inhibition targets bioenergetic homeostasis in AML MOLM-14 cells in vitro and in vivo and synergizes with cytarabine and venetoclax. J Exp Clin Cancer Res. 2022;41. https:\/\/doi.org\/10.1186\/s13046-022-02542-8. [cited 2026 Mar 31].","DOI":"10.1186\/s13046-022-02542-8"},{"key":"2749_CR97","doi-asserted-by":"publisher","unstructured":"Cencic R, Im YK, Naineni SK, Moustafa-Kamal M, Jovanovic P, Sabourin V, et al. A second-generation eIF4A RNA helicase inhibitor exploits translational reprogramming as a vulnerability in triple-negative breast cancer. Proc Natl Acad Sci U S A. 2024;121. https:\/\/doi.org\/10.1073\/pnas.2318093121. [cited 2026 Mar 31].","DOI":"10.1073\/pnas.2318093121"},{"key":"2749_CR98","doi-asserted-by":"publisher","first-page":"e2424286122","DOI":"10.1073\/pnas.2424286122","volume":"122","author":"JA Boyer","year":"2025","unstructured":"Boyer JA, Rosen EY, Sharma M, Dorso MA, Mai N, Amor C, et al. eIF4A controls translation of estrogen receptor alpha and is a therapeutic target in advanced breast cancer. Proc Natl Acad Sci U S A. 2025;122:e2424286122. https:\/\/doi.org\/10.1073\/pnas.2424286122. [cited 2026 Mar 31].","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2749_CR99","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-97765-8","author":"L Shen","year":"2021","unstructured":"Shen L, Pugsley L, Cencic R, Wang HC, Robert F, Naineni SK, et al. A forward genetic screen identifies modifiers of rocaglate responsiveness. Sci Rep. 2021. https:\/\/doi.org\/10.1038\/s41598-021-97765-8. [cited 2026 Mar 31]. 11.","journal-title":"Sci Rep"},{"key":"2749_CR100","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.81302","author":"M Chen","year":"2023","unstructured":"Chen M, Kumakura N, Saito H, Muller R, Nishimoto M, Mito M, et al. A parasitic fungus employs mutated eIF4A to survive on rocaglate-synthesizing Aglaia plants. Elife. 2023. https:\/\/doi.org\/10.7554\/eLife.81302. [cited 2026 Mar 31]. 12.","journal-title":"Elife"},{"key":"2749_CR101","doi-asserted-by":"publisher","unstructured":"Costa-Mattioli M, Walter P. The integrated stress response: From mechanism to disease. Science. 2020;368. https:\/\/doi.org\/10.1126\/SCIENCE.AAT5314. [cited 2026 Apr 5].","DOI":"10.1126\/SCIENCE.AAT5314"},{"key":"2749_CR102","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.15252\/EMBR.201642195","volume":"17","author":"K Pakos-Zebrucka","year":"2016","unstructured":"Pakos-Zebrucka K, Koryga I, Mnich K, Ljujic M, Samali A, Gorman AM. The integrated stress response. EMBO Rep. 2016;17:1374\u201395. https:\/\/doi.org\/10.15252\/EMBR.201642195. [cited 2026 Apr 5].","journal-title":"EMBO Rep"},{"key":"2749_CR103","doi-asserted-by":"publisher","DOI":"10.1101\/CSHPERSPECT.A032870","author":"RC Wek","year":"2018","unstructured":"Wek RC. Role of eIF2\u03b1 Kinases in Translational Control and Adaptation to Cellular Stress. Cold Spring Harb Perspect Biol. 2018. https:\/\/doi.org\/10.1101\/CSHPERSPECT.A032870. [cited 2026 Apr 5]. 10.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"2749_CR104","doi-asserted-by":"publisher","unstructured":"Gordiyenko Y, Ll\u00e1cer JL, Ramakrishnan V. Structural basis for the inhibition of translation through eIF2\u03b1 phosphorylation. Nat Commun. 2019;10. https:\/\/doi.org\/10.1038\/S41467-019-10606-1. [cited 2026 Apr 5].","DOI":"10.1038\/S41467-019-10606-1"},{"key":"2749_CR105","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1126\/SCIENCE.AAW2922","volume":"364","author":"LR Kenner","year":"2019","unstructured":"Kenner LR, Anand AA, Nguyen HC, Myasnikov AG, Klose CJ, McGeever LA, et al. eIF2B-catalyzed nucleotide exchange and phosphoregulation by the integrated stress response. Science. 2019;364:491\u20135. https:\/\/doi.org\/10.1126\/SCIENCE.AAW2922. [cited 2026 Apr 5].","journal-title":"Science"},{"key":"2749_CR106","doi-asserted-by":"publisher","unstructured":"Farooq Z, Kusuma F, Burke P, Dufour CR, Lee D, Tabatabaei N, et al. The amino acid sensor GCN2 suppresses terminal oligopyrimidine (TOP) mRNA translation via La-related protein 1 (LARP1). J Biol Chem. 2022;298. https:\/\/doi.org\/10.1016\/j.jbc.2022.102277. [cited 2026 Apr 5].","DOI":"10.1016\/j.jbc.2022.102277"},{"key":"2749_CR107","doi-asserted-by":"publisher","first-page":"11269","DOI":"10.1073\/PNAS.0400541101","volume":"101","author":"KM Vattem","year":"2004","unstructured":"Vattem KM, Wek RC. Reinitiation involving upstream ORFs regulates ATF4 mRNA translation in mammalian cells. Proc Natl Acad Sci U S A. 2004;101:11269\u201374. https:\/\/doi.org\/10.1073\/PNAS.0400541101. [cited 2026 Apr 5].","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2749_CR108","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1083\/JCB.200408003","volume":"167","author":"PD Lu","year":"2004","unstructured":"Lu PD, Harding HP, Ron D. Translation reinitiation at alternative open reading frames regulates gene expression in an integrated stress response. J Cell Biol. 2004;167:27\u201333. https:\/\/doi.org\/10.1083\/JCB.200408003. [cited 2026 Apr 5].","journal-title":"J Cell Biol"},{"key":"2749_CR109","doi-asserted-by":"publisher","unstructured":"Andreev DE, O\u2019connor PB, Fahey C, Kenny EM, Terenin IM, Dmitriev SE, et al. Translation of 5\u2019 leaders is pervasive in genes resistant to eIF2 repression. Elife. 2015;4. https:\/\/doi.org\/10.7554\/ELIFE.03971. [cited 2026 Apr 5].","DOI":"10.7554\/ELIFE.03971"},{"key":"2749_CR110","doi-asserted-by":"publisher","unstructured":"Ryoo HD. The integrated stress response in metabolic adaptation. J Biol Chem. 2024;300. https:\/\/doi.org\/10.1016\/j.jbc.2024.107151. [cited 2026 Apr 5].","DOI":"10.1016\/j.jbc.2024.107151"},{"key":"2749_CR111","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/j.celrep.2018.10.021","volume":"25","author":"P van Galen","year":"2018","unstructured":"van Galen P, Mbong N, Kreso A, Schoof EM, Wagenblast E, Ng SWK, et al. Integrated Stress Response Activity Marks Stem Cells in Normal Hematopoiesis and Leukemia. Cell Rep. 2018;25:1109\u2013e11175. https:\/\/doi.org\/10.1016\/j.celrep.2018.10.021. [cited 2026 Apr 5].","journal-title":"Cell Rep"},{"key":"2749_CR112","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1038\/S43018-020-00126-Z","volume":"1","author":"BM Stevens","year":"2020","unstructured":"Stevens BM, Jones CL, Pollyea DA, Culp-Hill R, D\u2019Alessandro A, Winters A, et al. Fatty acid metabolism underlies venetoclax resistance in acute myeloid leukemia stem cells. Nat Cancer. 2020;1:1176\u201387. https:\/\/doi.org\/10.1038\/S43018-020-00126-Z. [cited 2026 Apr 5].","journal-title":"Nat Cancer"},{"key":"2749_CR113","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.ccell.2018.10.005","volume":"34","author":"CL Jones","year":"2018","unstructured":"Jones CL, Stevens BM, D\u2019Alessandro A, Reisz JA, Culp-Hill R, Nemkov T, et al. Inhibition of Amino Acid Metabolism Selectively Targets Human Leukemia Stem Cells. Cancer Cell. 2018;34:724\u2013e7404. https:\/\/doi.org\/10.1016\/j.ccell.2018.10.005. [cited 2026 Apr 5].","journal-title":"Cancer Cell"},{"key":"2749_CR114","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/j.stem.2020.07.021","volume":"27","author":"CL Jones","year":"2020","unstructured":"Jones CL, Stevens BM, Pollyea DA, Culp-Hill R, Reisz JA, Nemkov T, et al. Nicotinamide Metabolism Mediates Resistance to Venetoclax in Relapsed Acute Myeloid Leukemia Stem Cells. Cell Stem Cell. 2020;27:748\u2013e7644. https:\/\/doi.org\/10.1016\/j.stem.2020.07.021. [cited 2026 Apr 5].","journal-title":"Cell Stem Cell"},{"key":"2749_CR115","doi-asserted-by":"publisher","first-page":"353","DOI":"10.3324\/HAEMATOL.2022.280800","volume":"108","author":"P Stelmach","year":"2023","unstructured":"Stelmach P, Trumpp A. Leukemic stem cells and therapy resistance in acute myeloid leukemia. Haematologica. 2023;108:353\u201366. https:\/\/doi.org\/10.3324\/HAEMATOL.2022.280800. [cited 2026 Apr 5].","journal-title":"Haematologica"},{"key":"2749_CR116","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1016\/j.immuni.2025.09.003","volume":"58","author":"C Alicea Pauneto","year":"2025","unstructured":"Alicea Pauneto C, del Riesenberg M, Gandy BP, Kennedy EJ, Clutton AS, Hem GT. Intra-tumoral hypoxia promotes CD8\u2009+\u2009T cell dysfunction via chronic activation of integrated stress response transcription factor ATF4. Immunity. 2025;58:2489\u2013e25048. https:\/\/doi.org\/10.1016\/j.immuni.2025.09.003. [cited 2026 Apr 5].","journal-title":"Immunity"},{"key":"2749_CR117","doi-asserted-by":"publisher","DOI":"10.1038\/S41586-026-10143-0","author":"JP Bossowski","year":"2026","unstructured":"Bossowski JP, Pillai R, Kilian J, Wong Lau A, Nakamura M, Rashidfarrokhi A, et al. The integrated stress response promotes immune evasion through lipocalin 2. Nature. 2026. https:\/\/doi.org\/10.1038\/S41586-026-10143-0. [cited 2026 Apr 5].","journal-title":"Nature"},{"key":"2749_CR118","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1038\/S41556-022-00918-8","volume":"24","author":"II Verginadis","year":"2022","unstructured":"Verginadis II, Avgousti H, Monslow J, Skoufos G, Chinga F, Kim K, et al. A stromal Integrated Stress Response activates perivascular cancer-associated fibroblasts to drive angiogenesis and tumour progression. Nat Cell Biol. 2022;24:940\u201353. https:\/\/doi.org\/10.1038\/S41556-022-00918-8. [cited 2026 Apr 5].","journal-title":"Nat Cell Biol"},{"key":"2749_CR119","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1083\/JCB.201702058","volume":"216","author":"PM Quir\u00f3s","year":"2017","unstructured":"Quir\u00f3s PM, Prado MA, Zamboni N, D\u2019Amico D, Williams RW, Finley D, et al. Multi-omics analysis identifies ATF4 as a key regulator of the mitochondrial stress response in mammals. J Cell Biol. 2017;216:2027\u201345. https:\/\/doi.org\/10.1083\/JCB.201702058. [cited 2026 Apr 5].","journal-title":"J Cell Biol"},{"key":"2749_CR120","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1016\/j.cmet.2023.10.011","volume":"35","author":"YW Cheng","year":"2023","unstructured":"Cheng YW, Liu J, Finkel T, Mitohormesis. Cell Metab. 2023;35:1872\u201386. https:\/\/doi.org\/10.1016\/j.cmet.2023.10.011. [cited 2026 Apr 5].","journal-title":"Cell Metab"},{"key":"2749_CR121","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1158\/2159-8290.CD-19-1008","volume":"10","author":"N Aroua","year":"2020","unstructured":"Aroua N, Boet E, Ghisi M, Nicolau-Travers ML, Saland E, Gwilliam R, et al. Extracellular ATP and CD39 Activate cAMP-Mediated Mitochondrial Stress Response to Promote Cytarabine Resistance in Acute Myeloid Leukemia. Cancer Discov. 2020;10:1544\u201365. https:\/\/doi.org\/10.1158\/2159-8290.CD-19-1008. [cited 2026 Apr 5].","journal-title":"Cancer Discov"},{"key":"2749_CR122","doi-asserted-by":"publisher","DOI":"10.1038\/S41419-020-02867-2","author":"A Roca-Portoles","year":"2020","unstructured":"Roca-Portoles A, Rodriguez-Blanco G, Sumpton D, Cloix C, Mullin M, Mackay GM, et al. Venetoclax causes metabolic reprogramming independent of BCL-2 inhibition. Cell Death Dis. 2020. https:\/\/doi.org\/10.1038\/S41419-020-02867-2. [cited 2026 Apr 5]. 11.","journal-title":"Cell Death Dis"},{"key":"2749_CR123","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1016\/j.stem.2024.09.008","volume":"31","author":"G Han","year":"2024","unstructured":"Han G, Cui M, Lu P, Zhang T, Yin R, Hu J, et al. Selective translation of nuclear mitochondrial respiratory proteins reprograms succinate metabolism in AML development and chemoresistance. Cell Stem Cell. 2024;31:1777\u2013e17939. https:\/\/doi.org\/10.1016\/j.stem.2024.09.008. [cited 2026 Apr 5].","journal-title":"Cell Stem Cell"},{"key":"2749_CR124","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1158\/2643-3230.BCD-20-0183","volume":"3","author":"M Li","year":"2022","unstructured":"Li M, Teater MR, Hong JY, Park NR, Duy C, Shen H, et al. Translational Activation of ATF4 through Mitochondrial Anaplerotic Metabolic Pathways Is Required for DLBCL Growth and Survival. Blood Cancer Discov. 2022;3:50\u201365. https:\/\/doi.org\/10.1158\/2643-3230.BCD-20-0183. [cited 2026 Apr 5].","journal-title":"Blood Cancer Discov"},{"key":"2749_CR125","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/NCB2738","volume":"15","author":"J Han","year":"2013","unstructured":"Han J, Back SH, Hur J, Lin YH, Gildersleeve R, Shan J, et al. ER-stress-induced transcriptional regulation increases protein synthesis leading to cell death. Nat Cell Biol. 2013;15:481\u201390. https:\/\/doi.org\/10.1038\/NCB2738. [cited 2026 Apr 5].","journal-title":"Nat Cell Biol"},{"key":"2749_CR126","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.tem.2017.07.003","volume":"28","author":"IMN Wortel","year":"2017","unstructured":"Wortel IMN, van der Meer LT, Kilberg MS, van Leeuwen FN. Surviving Stress: Modulation of ATF4-Mediated Stress Responses in Normal and Malignant Cells. Trends Endocrinol Metabolism. 2017;28:794\u2013806. https:\/\/doi.org\/10.1016\/j.tem.2017.07.003. [cited 2026 Apr 5].","journal-title":"Trends Endocrinol Metabolism"},{"key":"2749_CR127","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ccell.2017.12.003","volume":"33","author":"DM Gwinn","year":"2018","unstructured":"Gwinn DM, Lee AG, Briones-Martin-del-Campo M, Conn CS, Simpson DR, Scott AI, et al. Oncogenic KRAS Regulates Amino Acid Homeostasis and Asparagine Biosynthesis via ATF4 and Alters Sensitivity to L-Asparaginase. Cancer Cell. 2018;33:91\u2013e1076. https:\/\/doi.org\/10.1016\/j.ccell.2017.12.003. [cited 2026 Apr 5].","journal-title":"Cancer Cell"},{"key":"2749_CR128","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.1182\/BLOOD.2022018258","volume":"141","author":"KM Rattigan","year":"2023","unstructured":"Rattigan KM, Zarou MM, Helgason GV. Metabolism in stem cell-driven leukemia: parallels between hematopoiesis and immunity. Blood. 2023;141:2553\u201365. https:\/\/doi.org\/10.1182\/BLOOD.2022018258. [cited 2026 Apr 5].","journal-title":"Blood"},{"key":"2749_CR129","doi-asserted-by":"publisher","first-page":"3386","DOI":"10.1182\/BLOODADVANCES.2022006965","volume":"6","author":"DC Ferguson","year":"2022","unstructured":"Ferguson DC, McCorkle JR, Barnett KR, Bonten EJ, Bergeron BP, Bhattarai KR, et al. Amino acid stress response genes promote L-asparaginase resistance in pediatric acute lymphoblastic leukemia. Blood Adv. 2022;6:3386\u201397. https:\/\/doi.org\/10.1182\/BLOODADVANCES.2022006965. [cited 2026 Apr 5].","journal-title":"Blood Adv"},{"key":"2749_CR130","doi-asserted-by":"publisher","unstructured":"Tameire F, Wojnarowicz PM, Fujisawa S, Huang S, Reilly O, Dudgeon C, et al. Activation of GCN2 by HC-7366 results in significant anti-tumor efficacy as monotherapy and in combination with Venetoclax in AML models. Blood Cancer Discov. 2023;A30\u201330. https:\/\/doi.org\/10.1158\/2643-3249.AML23-A30. [cited 2026 Apr 5].","DOI":"10.1158\/2643-3249.AML23-A30"},{"key":"2749_CR131","doi-asserted-by":"publisher","DOI":"10.7554\/ELIFE.00498","author":"C Sidrauski","year":"2013","unstructured":"Sidrauski C, Acosta-Alvear D, Khoutorsky A, Vedantham P, Hearn BR, Li H, et al. Pharmacological brake-release of mRNA translation enhances cognitive memory. Elife. 2013. https:\/\/doi.org\/10.7554\/ELIFE.00498. [cited 2026 Apr 5]. 2.","journal-title":"Elife"},{"key":"2749_CR132","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1126\/SCIENCE.AAR5129","volume":"359","author":"AF Zyryanova","year":"2018","unstructured":"Zyryanova AF, Weis F, Faille A, Abo Alard A, Crespillo-Casado A, Sekine Y, et al. Binding of ISRIB reveals a regulatory site in the nucleotide exchange factor eIF2B. Science. 2018;359:1533\u20136. https:\/\/doi.org\/10.1126\/SCIENCE.AAR5129. [cited 2026 Apr 5].","journal-title":"Science"},{"key":"2749_CR133","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1038\/S41586-025-08794-6","volume":"641","author":"CW Chen","year":"2025","unstructured":"Chen CW, Papadopoli D, Szkop KJ, Guan BJ, Alzahrani M, Wu J, et al. Plasticity of the mammalian integrated stress response. Nature. 2025;641:1319\u201328. https:\/\/doi.org\/10.1038\/S41586-025-08794-6. [cited 2026 Apr 5].","journal-title":"Nature"},{"key":"2749_CR134","doi-asserted-by":"publisher","first-page":"9502","DOI":"10.1038\/S41467-025-64577-7","volume":"16","author":"P Jiang","year":"2025","unstructured":"Jiang P, Bian Q. Pre-established ATF4 occupancy and chromatin organization instruct selective transcription activation during integrated stress response. Nat Commun. 2025;16:9502. https:\/\/doi.org\/10.1038\/S41467-025-64577-7. [cited 2026 Apr 5].","journal-title":"Nat Commun"},{"key":"2749_CR135","doi-asserted-by":"publisher","DOI":"10.1038\/S41419-020-2727-2","author":"JAMY Choo","year":"2020","unstructured":"Choo JAMY, Schl\u00f6sser D, Manzini V, Magerhans A, Dobbelstein M. The integrated stress response induces R-loops and hinders replication fork progression. Cell Death Dis. 2020. https:\/\/doi.org\/10.1038\/S41419-020-2727-2. [cited 2026 Apr 5]. 11.","journal-title":"Cell Death Dis"},{"key":"2749_CR136","doi-asserted-by":"publisher","unstructured":"Perner F, Schnoeder TM, Xiong Y, Jayavelu AK, Mashamba N, Santamaria NT et al. YBX1 mediates translation of oncogenic transcripts to control cell competition in AML. Leukemia;36:426\u201337. https:\/\/doi.org\/10.1038\/S41375-021-01393-0. [cited 2026 Apr 5].","DOI":"10.1038\/S41375-021-01393-0"},{"key":"2749_CR137","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1182\/BLOOD.2020009676","volume":"138","author":"M Feng","year":"2021","unstructured":"Feng M, Xie X, Han G, Zhang T, Li Y, Li Y, et al. YBX1 is required for maintaining myeloid leukemia cell survival by regulating BCL2 stability in an m6A-dependent manner. Blood. 2021;138:71\u201385. https:\/\/doi.org\/10.1182\/BLOOD.2020009676. [cited 2026 Apr 5].","journal-title":"Blood"},{"key":"2749_CR138","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.molcel.2008.03.018","volume":"30","author":"L Marash","year":"2008","unstructured":"Marash L, Liberman N, Henis-Korenblit S, Sivan G, Reem E, Elroy-Stein O, et al. DAP5 Promotes Cap-Independent Translation of Bcl-2 and CDK1 to Facilitate Cell Survival during Mitosis. Mol Cell. 2008;30:447\u201359. https:\/\/doi.org\/10.1016\/j.molcel.2008.03.018. [cited 2026 Apr 28].","journal-title":"Mol Cell"},{"key":"2749_CR139","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1038\/ONC.2015.247","volume":"35","author":"S Emmrich","year":"2016","unstructured":"Emmrich S, Engeland F, El-Khatib M, Henke K, Obulkasim A, Sch\u00f6ning J, et al. miR-139-5p controls translation in myeloid leukemia through EIF4G2. Oncogene. 2016;35:1822\u201331. https:\/\/doi.org\/10.1038\/ONC.2015.247. [cited 2026 Apr 28].","journal-title":"Oncogene"},{"key":"2749_CR140","doi-asserted-by":"publisher","unstructured":"Nogueira G, Fernandes R, Garc\u00eda-Moreno JF, Rom\u00e3o L. Nonsense-mediated RNA decay and its bipolar function in cancer. Mol Cancer. 2021;20. https:\/\/doi.org\/10.1186\/S12943-021-01364-0. [cited 2026 Jun 29].","DOI":"10.1186\/S12943-021-01364-0"},{"key":"2749_CR141","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1038\/S41588-019-0517-5","volume":"51","author":"RGH Lindeboom","year":"2019","unstructured":"Lindeboom RGH, Vermeulen M, Lehner B, Supek F. The impact of nonsense-mediated mRNA decay on genetic disease, gene editing and cancer immunotherapy. Nat Genet. 2019;51:1645\u201351. https:\/\/doi.org\/10.1038\/S41588-019-0517-5. [cited 2026 Jun 29].","journal-title":"Nat Genet"},{"key":"2749_CR142","doi-asserted-by":"publisher","unstructured":"Kanellis DC, Espinoza JA, Zisi A, Sakkas E, Bartkova J, Katsori AM, et al. The exon-junction complex helicase eIF4A3 controls cell fate via coordinated regulation of ribosome biogenesis and translational output. Sci Adv. 2021;7. https:\/\/doi.org\/10.1126\/SCIADV.ABF7561. [cited 2026 Jun 29].","DOI":"10.1126\/SCIADV.ABF7561"},{"key":"2749_CR143","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/S41375-023-02098-2","volume":"38","author":"S Miliara","year":"2024","unstructured":"Miliara S, Cozzi E, Zhong X, Chan I, Ekwall K, Lehmann S, et al. The exon-junction complex helicase eIF4A3 holds therapeutic potential in acute myeloid leukemia. Leukemia. 2024;38:663\u20136. https:\/\/doi.org\/10.1038\/S41375-023-02098-2. [cited 2026 Jun 29].","journal-title":"Leukemia"},{"key":"2749_CR144","doi-asserted-by":"publisher","unstructured":"Liu L, Vujovic A, Deshpande NP, Sathe S, Anande G, Chen HTT, et al. The splicing factor RBM17 drives leukemic stem cell maintenance by evading nonsense-mediated decay of pro-leukemic factors. Nat Commun. 2022;13. https:\/\/doi.org\/10.1038\/S41467-022-31155-0. [cited 2026 Jun 29].","DOI":"10.1038\/S41467-022-31155-0"},{"key":"2749_CR145","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1038\/NM.4416","volume":"23","author":"LP Vu","year":"2017","unstructured":"Vu LP, Pickering BF, Cheng Y, Zaccara S, Nguyen D, Minuesa G, et al. The N6-methyladenosine (m6A)-forming enzyme METTL3 controls myeloid differentiation of normal hematopoietic and leukemia cells. Nat Med. 2017;23:1369\u201376. https:\/\/doi.org\/10.1038\/NM.4416. [cited 2026 Apr 5].","journal-title":"Nat Med"},{"key":"2749_CR146","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/S41586-018-0538-8","volume":"561","author":"J Choe","year":"2018","unstructured":"Choe J, Lin S, Zhang W, Liu Q, Wang L, Ramirez-Moya J, et al. mRNA circularization by METTL3-eIF3h enhances translation and promotes oncogenesis. Nature. 2018;561:556\u201360. https:\/\/doi.org\/10.1038\/S41586-018-0538-8. [cited 2026 Apr 5].","journal-title":"Nature"},{"key":"2749_CR147","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1038\/90054","volume":"28","author":"Z Ma","year":"2001","unstructured":"Ma Z, Morris SW, Valentine V, Herbrick LM, Cui JA. Fusion of two novel genes, RBM15 and MKL1, in the t(1;22)(p13;q13) of acute megakaryoblastic leukemia. Nat Genet. 2001;28:220\u20131. https:\/\/doi.org\/10.1038\/90054. [cited 2026 Apr 5].","journal-title":"Nat Genet"},{"key":"2749_CR148","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/j.cell.2015.05.014","volume":"161","author":"X Wang","year":"2015","unstructured":"Wang X, Zhao BS, Roundtree IA, Lu Z, Han D, Ma H, et al. N6-methyladenosine modulates messenger RNA translation efficiency. Cell. 2015;161:1388\u201399. https:\/\/doi.org\/10.1016\/j.cell.2015.05.014. [cited 2026 Apr 5].","journal-title":"Cell"},{"key":"2749_CR149","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1016\/j.cell.2020.05.012","volume":"181","author":"S Zaccara","year":"2020","unstructured":"Zaccara S, Jaffrey SR. A Unified Model for the Function of YTHDF Proteins in Regulating m6A-Modified mRNA. Cell. 2020;181:1582\u2013e159518. https:\/\/doi.org\/10.1016\/j.cell.2020.05.012. [cited 2026 Apr 5].","journal-title":"Cell"},{"key":"2749_CR150","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/S41556-018-0045-Z","volume":"20","author":"H Huang","year":"2018","unstructured":"Huang H, Weng H, Sun W, Qin X, Shi H, Wu H, et al. Recognition of RNA N6-methyladenosine by IGF2BP proteins enhances mRNA stability and translation. Nat Cell Biol. 2018;20:285\u201395. https:\/\/doi.org\/10.1038\/S41556-018-0045-Z. [cited 2026 Apr 5].","journal-title":"Nat Cell Biol"},{"key":"2749_CR151","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/j.cell.2015.10.012","volume":"163","author":"KD Meyer","year":"2015","unstructured":"Meyer KD, Patil DP, Zhou J, Zinoviev A, Skabkin MA, Elemento O, et al. 5\u2032 UTR m6A Promotes Cap-Independent Translation. Cell. 2015;163:999\u20131010. https:\/\/doi.org\/10.1016\/j.cell.2015.10.012. [cited 2026 Apr 5].","journal-title":"Cell"},{"key":"2749_CR152","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1038\/NM.2187","volume":"16","author":"MG Kharas","year":"2010","unstructured":"Kharas MG, Lengner CJ, Al-Shahrour F, Bullinger L, Ball B, Zaidi S, et al. Musashi-2 regulates normal hematopoiesis and promotes aggressive myeloid leukemia. Nat Med. 2010;16:903\u20138. https:\/\/doi.org\/10.1038\/NM.2187. [cited 2026 Apr 5].","journal-title":"Nat Med"},{"key":"2749_CR153","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1172\/JCI78440","volume":"125","author":"SM Park","year":"2015","unstructured":"Park SM, G\u00f6nen M, Vu L, Minuesa G, Tivnan P, Barlowe TS, et al. Musashi2 sustains the mixed-lineage leukemia-driven stem cell regulatory program. J Clin Invest. 2015;125:1286\u201398. https:\/\/doi.org\/10.1172\/JCI78440. [cited 2026 Apr 5].","journal-title":"J Clin Invest"},{"key":"2749_CR154","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/NATURE09171","volume":"466","author":"T Ito","year":"2010","unstructured":"Ito T, Kwon HY, Zimdahl B, Congdon KL, Blum J, Lento WE, et al. Regulation of myeloid leukaemia by the cell-fate determinant Musashi. Nature. 2010;466:765\u20138. https:\/\/doi.org\/10.1038\/NATURE09171. [cited 2026 Apr 5].","journal-title":"Nature"},{"key":"2749_CR155","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1038\/NG.3854","volume":"49","author":"LP Vu","year":"2017","unstructured":"Vu LP, Prieto C, Amin EM, Chhangawala S, Krivtsov A, Calvo-Vidal MN, et al. Functional screen of MSI2 interactors identifies an essential role for SYNCRIP in myeloid leukemia stem cells. Nat Genet. 2017;49:866\u201375. https:\/\/doi.org\/10.1038\/NG.3854. [cited 2026 Apr 5].","journal-title":"Nat Genet"},{"key":"2749_CR156","doi-asserted-by":"publisher","first-page":"2935","DOI":"10.1038\/S41375-025-02768-3","volume":"39","author":"T Setiawan","year":"2025","unstructured":"Setiawan T, Muhammad JA, Marcellina N, Wirawan LM, Jun N, Sari IN, et al. Regulation of metabolic adaptation and leukemia progression by MUSASHI2-DEPTOR-KIF11 axis. Leukemia. 2025;39:2935\u201345. https:\/\/doi.org\/10.1038\/S41375-025-02768-3. [cited 2026 Apr 5].","journal-title":"Leukemia"},{"key":"2749_CR157","doi-asserted-by":"publisher","DOI":"10.1038\/S41467-019-10523-3","author":"G Minuesa","year":"2019","unstructured":"Minuesa G, Albanese SK, Xie W, Kazansky Y, Worroll D, Chow A, et al. Small-molecule targeting of MUSASHI RNA-binding activity in acute myeloid leukemia. Nat Commun. 2019. https:\/\/doi.org\/10.1038\/S41467-019-10523-3. [cited 2026 Apr 5]. 10.","journal-title":"Nat Commun"},{"key":"2749_CR158","doi-asserted-by":"publisher","first-page":"3745","DOI":"10.1038\/EMBOJ.2012.220","volume":"31","author":"R Soto-Rifo","year":"2012","unstructured":"Soto-Rifo R, Rubilar PS, Limousin T, De Breyne S, D\u00e9cimo D, Ohlmann T. DEAD-box protein DDX3 associates with eIF4F to promote translation of selected mRNAs. EMBO J. 2012;31:3745\u201356. https:\/\/doi.org\/10.1038\/EMBOJ.2012.220. [cited 2026 Apr 5].","journal-title":"EMBO J"},{"key":"2749_CR159","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1038\/NG.33580","volume":"47","author":"L Jiang","year":"2015","unstructured":"Jiang L, Gu ZH, Yan ZX, Zhao X, Xie YY, Zhang ZG, et al. Exome sequencing identifies somatic mutations of DDX3X in natural killer\/T-cell lymphoma. Nat Genet. 2015;47:1061\u20136. https:\/\/doi.org\/10.1038\/NG.33580. [cited 2026 Apr 5].","journal-title":"Nat Genet"},{"key":"2749_CR160","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/NG.2508","volume":"45","author":"K De Keersmaecker","year":"2013","unstructured":"De Keersmaecker K, Atak ZK, Li N, Vicente C, Patchett S, Girardi T, et al. Exome sequencing identifies mutation in CNOT3 and ribosomal genes RPL5 and RPL10 in T-cell acute lymphoblastic leukemia. Nat Genet. 2013;45:186\u201390. https:\/\/doi.org\/10.1038\/NG.2508. [cited 2026 Apr 5].","journal-title":"Nat Genet"},{"key":"2749_CR161","doi-asserted-by":"publisher","first-page":"4059","DOI":"10.1016\/j.molcel.2021.07.041","volume":"81","author":"C Gong","year":"2021","unstructured":"Gong C, Krupka JA, Gao J, Grigoropoulos NF, Giotopoulos G, Asby R, et al. Sequential inverse dysregulation of the RNA helicases DDX3X and DDX3Y facilitates MYC-driven lymphomagenesis. Mol Cell. 2021;81:4059\u2013e407511. https:\/\/doi.org\/10.1016\/j.molcel.2021.07.041. [cited 2026 Apr 5].","journal-title":"Mol Cell"},{"key":"2749_CR162","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/NATURE14267","volume":"522","author":"ASY Lee","year":"2015","unstructured":"Lee ASY, Kranzusch PJ, Cate JHD. eIF3 targets cell-proliferation messenger RNAs for translational activation or repression. Nature. 2015;522:111\u20134. https:\/\/doi.org\/10.1038\/NATURE14267. [cited 2026 Apr 5].","journal-title":"Nature"},{"key":"2749_CR163","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/NATURE18954","volume":"536","author":"ASY Lee","year":"2016","unstructured":"Lee ASY, Kranzusch PJ, Doudna JA, Cate JHD. eIF3d is an mRNA cap-binding protein that is required for specialized translation initiation. Nature. 2016;536:96\u20139. https:\/\/doi.org\/10.1038\/NATURE18954. [cited 2026 Apr 5].","journal-title":"Nature"},{"key":"2749_CR164","doi-asserted-by":"publisher","first-page":"12031","DOI":"10.1073\/PNAS.192442499","volume":"99","author":"VP Mauro","year":"2002","unstructured":"Mauro VP, Edelman GM. The ribosome filter hypothesis. Proc Natl Acad Sci U S A. 2002;99:12031\u20136. https:\/\/doi.org\/10.1073\/PNAS.192442499. [cited 2026 Apr 5].","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2749_CR165","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/J.CELL.2011.03.028","volume":"145","author":"N Kondrashov","year":"2011","unstructured":"Kondrashov N, Pusic A, Stumpf CR, Shimizu K, Hsieh AC, Xue S, et al. Ribosome-mediated specificity in Hox mRNA translation and vertebrate tissue patterning. Cell. 2011;145:383\u201397. https:\/\/doi.org\/10.1016\/J.CELL.2011.03.028. [cited 2026 Jun 30].","journal-title":"Cell"},{"key":"2749_CR166","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.molcel.2018.07.018","volume":"71","author":"NR Genuth","year":"2018","unstructured":"Genuth NR, Barna M. The Discovery of Ribosome Heterogeneity and Its Implications for Gene Regulation and Organismal Life. Mol Cell. 2018;71:364\u201374. https:\/\/doi.org\/10.1016\/j.molcel.2018.07.018. [cited 2026 Apr 5].","journal-title":"Mol Cell"},{"key":"2749_CR167","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/S41576-018-0008-Z","volume":"19","author":"NR Genuth","year":"2018","unstructured":"Genuth NR, Barna M. Heterogeneity and specialized functions of translation machinery: from genes to organisms. Nat Rev Genet. 2018;19:431\u201352. https:\/\/doi.org\/10.1038\/S41576-018-0008-Z. [cited 2026 Apr 5].","journal-title":"Nat Rev Genet"},{"key":"2749_CR168","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.molcel.2017.05.021","volume":"67","author":"Z Shi","year":"2017","unstructured":"Shi Z, Fujii K, Kovary KM, Genuth NR, R\u00f6st HL, Teruel MN, et al. Heterogeneous Ribosomes Preferentially Translate Distinct Subpools of mRNAs Genome-wide. Mol Cell. 2017;67:71\u201383. https:\/\/doi.org\/10.1016\/j.molcel.2017.05.021. .e7.","journal-title":"Mol Cell"},{"key":"2749_CR169","doi-asserted-by":"publisher","unstructured":"Genuth NR, Shi Z, Kunimoto K, Hung V, Xu AF, Kerr CH, et al. A stem cell roadmap of ribosome heterogeneity reveals a function for RPL10A in mesoderm production. Nat Commun. 2022;13. https:\/\/doi.org\/10.1038\/S41467-022-33263-3. [cited 2026 Apr 5].","DOI":"10.1038\/S41467-022-33263-3"},{"key":"2749_CR170","doi-asserted-by":"publisher","unstructured":"Aspden J, Faller WJ, Barna M, Lund A. Ribosome heterogeneity and specialization. Philos Trans R Soc Lond B Biol Sci. 2025;380. https:\/\/doi.org\/10.1098\/RSTB.2023.0375. [cited 2026 Apr 5].","DOI":"10.1098\/RSTB.2023.0375"},{"key":"2749_CR171","doi-asserted-by":"publisher","first-page":"6981","DOI":"10.1016\/j.cell.2024.09.039","volume":"187","author":"A Dopler","year":"2024","unstructured":"Dopler A, Alkan F, Malka Y, van der Kammen R, Hoefakker K, Taranto D, et al. P-stalk ribosomes act as master regulators of cytokine-mediated processes. Cell. 2024;187:6981\u201393. https:\/\/doi.org\/10.1016\/j.cell.2024.09.039. .e23.","journal-title":"Cell"},{"key":"2749_CR172","doi-asserted-by":"publisher","DOI":"10.1093\/NARCAN\/ZCAE032","author":"P Fuentes","year":"2024","unstructured":"Fuentes P, Pelletier J, Gentilella A. Decoding ribosome complexity: role of ribosomal proteins in cancer and disease. NAR Cancer. 2024. https:\/\/doi.org\/10.1093\/NARCAN\/ZCAE032. [cited 2026 Apr 5]. 6.","journal-title":"NAR Cancer"},{"key":"2749_CR173","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1158\/0008-5472.CAN-21-4087","volume":"82","author":"AR Elhamamsy","year":"2022","unstructured":"Elhamamsy AR, Metge BJ, Alsheikh HA, Shevde LA, Samant RS. Ribosome Biogenesis: A Central Player in Cancer Metastasis and Therapeutic Resistance. Cancer Res. 2022;82:2344\u201353. https:\/\/doi.org\/10.1158\/0008-5472.CAN-21-4087. [cited 2026 Apr 5].","journal-title":"Cancer Res"},{"key":"2749_CR174","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1038\/LEU.2017.225","volume":"32","author":"T Girardi","year":"2018","unstructured":"Girardi T, Vereecke S, Sulima SO, Khan Y, Fancello L, Briggs JW, et al. The T-cell leukemia-associated ribosomal RPL10 R98S mutation enhances JAK-STAT signaling. Leukemia. 2018;32:809\u201319. https:\/\/doi.org\/10.1038\/LEU.2017.225. [cited 2026 Apr 5].","journal-title":"Leukemia"},{"key":"2749_CR175","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1002\/ELSC.202100124","volume":"22","author":"B Verbelen","year":"2022","unstructured":"Verbelen B, Girardi T, Sulima SO, Vereecke S, Verstraete P, Verbeeck J, et al. Exploitation of the ribosomal protein L10 R98S mutation to enhance recombinant protein production in mammalian cells. Eng Life Sci. 2022;22:100. https:\/\/doi.org\/10.1002\/ELSC.202100124. [cited 2026 Jun 30].","journal-title":"Eng Life Sci"},{"key":"2749_CR176","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.cell.2017.06.010","volume":"170","author":"A Tsherniak","year":"2017","unstructured":"Tsherniak A, Vazquez F, Montgomery PG, Weir BA, Kryukov G, Cowley GS, et al. Defining a Cancer Dependency Map. Cell. 2017;170:564\u2013e576. https:\/\/doi.org\/10.1016\/j.cell.2017.06.010. [cited 2026 Apr 5]. 16.","journal-title":"Cell"},{"key":"2749_CR177","doi-asserted-by":"publisher","unstructured":"Bacci L, Pollutri D, Ripa IJ, D\u2019Andrea M, Marchand V, Motorin Y, et al. Ribosomal protein L5 (RPL5\/uL18) I60V mutation is associated to increased translation and modulates drug sensitivity in T-cell acute lymphoblastic leukemia cells. Biochem Pharmacol. 2026;243. https:\/\/doi.org\/10.1016\/j.bcp.2025.117497. [cited 2026 Jun 30].","DOI":"10.1016\/j.bcp.2025.117497"},{"key":"2749_CR178","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1073\/PNAS.1816202116","volume":"116","author":"CP Walczak","year":"2019","unstructured":"Walczak CP, Leto DE, Zhang L, Riepe C, Muller RY, DaRosa PA, et al. Ribosomal protein RPL26 is the principal target of UFMylation. Proc Natl Acad Sci U S A. 2019;116:1299\u2013308. https:\/\/doi.org\/10.1073\/PNAS.1816202116. [cited 2026 Apr 5].","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2749_CR179","doi-asserted-by":"publisher","first-page":"5417","DOI":"10.1074\/jbc.M109.036814","volume":"285","author":"K Tatsumi","year":"2010","unstructured":"Tatsumi K, Sou YS, Tada N, Nakamura E, Iemura SI, Natsume T, et al. A novel type of E3 ligase for the Ufm1 conjugation system. J Biol Chem. 2010;285:5417\u201327. https:\/\/doi.org\/10.1074\/jbc.M109.036814. [cited 2026 Apr 5].","journal-title":"J Biol Chem"},{"key":"2749_CR180","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1101\/GAD.351605","volume":"19","author":"I Ruvinsky","year":"2005","unstructured":"Ruvinsky I, Sharon N, Lerer T, Cohen H, Stolovich-Rain M, Nir T, et al. Ribosomal protein S6 phosphorylation is a determinant of cell size and glucose homeostasis. Genes Dev. 2005;19:2199\u2013211. https:\/\/doi.org\/10.1101\/GAD.351605. [cited 2026 Apr 5].","journal-title":"Genes Dev"},{"key":"2749_CR181","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1016\/j.cell.2017.05.022","volume":"169","author":"D Simsek","year":"2017","unstructured":"Simsek D, Tiu GC, Flynn RA, Byeon GW, Leppek K, Xu AF, et al. The Mammalian Ribo-interactome Reveals Ribosome Functional Diversity and Heterogeneity. Cell. 2017;169:1051\u201365. https:\/\/doi.org\/10.1016\/j.cell.2017.05.022. [cited 2026 Jun 30]. .e18.","journal-title":"Cell"},{"key":"2749_CR182","doi-asserted-by":"publisher","unstructured":"Krokowski D, Jobava R, Szkop KJ, Chen CW, Fu X, Venus S, et al. Stress-induced perturbations in intracellular amino acids reprogram mRNA translation in osmoadaptation independently of the ISR. Cell Rep. 2022;40. https:\/\/doi.org\/10.1016\/j.celrep.2022.111092. [cited 2026 Jun 30].","DOI":"10.1016\/j.celrep.2022.111092"},{"key":"2749_CR183","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/j.cell.2014.10.041","volume":"159","author":"K Majzoub","year":"2014","unstructured":"Majzoub K, Hafirassou ML, Meignin C, Goto A, Marzi S, Fedorova A, et al. RACK1 controls IRES-mediated translation of viruses. Cell. 2014;159:1086\u201395. https:\/\/doi.org\/10.1016\/j.cell.2014.10.041. [cited 2026 Apr 5].","journal-title":"Cell"},{"key":"2749_CR184","doi-asserted-by":"publisher","unstructured":"Thompson MK, Rojas-Duran MF, Gangaramani P, Gilbert WV. The ribosomal protein Asc1\/RACK1 is required for efficient translation of short mRNAs. Elife. 2016;5. https:\/\/doi.org\/10.7554\/ELIFE.11154. [cited 2026 Apr 5].","DOI":"10.7554\/ELIFE.11154"},{"key":"2749_CR185","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/j.ccr.2011.04.018","volume":"19","author":"A Miluzio","year":"2011","unstructured":"Miluzio A, Beugnet A, Grosso S, Brina D, Mancino M, Campaner S, et al. Impairment of cytoplasmic eIF6 activity restricts lymphomagenesis and tumor progression without affecting normal growth. Cancer Cell. 2011;19:765\u201375. https:\/\/doi.org\/10.1016\/j.ccr.2011.04.018. [cited 2026 Apr 5].","journal-title":"Cancer Cell"},{"key":"2749_CR186","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/NATURE13035","volume":"509","author":"RAJ Signer","year":"2014","unstructured":"Signer RAJ, Magee JA, Salic A, Morrison SJ. Haematopoietic stem cells require a highly regulated protein synthesis rate. Nature. 2014;509:49\u201354. https:\/\/doi.org\/10.1038\/NATURE13035. [cited 2026 Apr 5].","journal-title":"Nature"},{"key":"2749_CR187","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/S0968-0004(02)02109-6","volume":"27","author":"WA Decatur","year":"2002","unstructured":"Decatur WA, Fournier MJ. rRNA modifications and ribosome function. Trends Biochem Sci. 2002;27:344\u201351. https:\/\/doi.org\/10.1016\/S0968-0004(02)02109-6. [cited 2026 Apr 6].","journal-title":"Trends Biochem Sci"},{"key":"2749_CR188","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.tibs.2015.07.008","volume":"40","author":"S Sharma","year":"2015","unstructured":"Sharma S, Lafontaine DLJ, \u2018View From A, Bridge\u2019:. A New Perspective on Eukaryotic rRNA Base Modification. Trends Biochem Sci. 2015;40:560\u201375. https:\/\/doi.org\/10.1016\/j.tibs.2015.07.008. [cited 2026 Apr 6].","journal-title":"Trends Biochem Sci"},{"key":"2749_CR189","doi-asserted-by":"publisher","DOI":"10.3390\/BIOM8040106","author":"P Lo Monaco","year":"2018","unstructured":"Lo Monaco P, Marcel V, Diaz JJ, Catez F. 2\u2019-O-Methylation of Ribosomal RNA: Towards an Epitranscriptomic Control of Translation? Biomolecules. 2018. https:\/\/doi.org\/10.3390\/BIOM8040106. [cited 2026 Apr 6]. 8.","journal-title":"Biomolecules"},{"key":"2749_CR190","doi-asserted-by":"publisher","first-page":"e983755","DOI":"10.4161\/23723556.2014.983755","volume":"2","author":"V Marcel","year":"2015","unstructured":"Marcel V, Catez F, Diaz JJ. Ribosome heterogeneity in tumorigenesis: the rRNA point of view. Mol Cell Oncol. 2015;2:e983755. https:\/\/doi.org\/10.4161\/23723556.2014.983755. [cited 2026 Apr 6].","journal-title":"Mol Cell Oncol"},{"key":"2749_CR191","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1002\/ANIE.201408362","volume":"54","author":"U Birkedal","year":"2015","unstructured":"Birkedal U, Christensen-Dalsgaard M, Krogh N, Sabarinathan R, Gorodkin J, Nielsen H. Profiling of ribose methylations in RNA by high-throughput sequencing. Angew Chem Int Ed Engl. 2015;54:451\u20135. https:\/\/doi.org\/10.1002\/ANIE.201408362. [cited 2026 Apr 6].","journal-title":"Angew Chem Int Ed Engl"},{"key":"2749_CR192","doi-asserted-by":"publisher","unstructured":"Marchand V, Blanloeil-Oillo F, Helm M, Motorin Y. Illumina-based RiboMethSeq approach for mapping of 2\u2019-O-Me residues in RNA. Nucleic Acids Res. 2016;44. https:\/\/doi.org\/10.1093\/NAR\/GKW547. [cited 2026 Apr 6].","DOI":"10.1093\/NAR\/GKW547"},{"key":"2749_CR193","doi-asserted-by":"publisher","first-page":"7884","DOI":"10.1093\/NAR\/GKW482","volume":"44","author":"N Krogh","year":"2016","unstructured":"Krogh N, Jansson MD, H\u00e4fner SJ, Tehler D, Birkedal U, Christensen-Dalsgaard M, et al. Profiling of 2\u2019-O-Me in human rRNA reveals a subset of fractionally modified positions and provides evidence for ribosome heterogeneity. Nucleic Acids Res. 2016;44:7884\u201395. https:\/\/doi.org\/10.1093\/NAR\/GKW482. [cited 2026 Apr 6].","journal-title":"Nucleic Acids Res"},{"key":"2749_CR194","doi-asserted-by":"publisher","first-page":"6784","DOI":"10.1073\/PNAS.1817334116\/-\/DCSUPPLEMENTAL","volume":"116","author":"V Khoddami","year":"2019","unstructured":"Khoddami V, Yerra A, Mosbruger TL, Fleming AM, Burrows CJ, Cairns BR. Transcriptome-wide profiling of multiple RNA modifications simultaneously at single-base resolution. Proc Natl Acad Sci U S A. 2019;116:6784\u20139. https:\/\/doi.org\/10.1073\/PNAS.1817334116\/-\/DCSUPPLEMENTAL. [cited 2026 Jun 30].","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2749_CR195","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/bs.mie.2015.03.011","volume":"560","author":"TM Carlile","year":"2015","unstructured":"Carlile TM, Rojas-Duran MF, Gilbert WV. Pseudo-Seq: Genome-Wide Detection of Pseudouridine Modifications in RNA. Methods Enzymol. 2015;560:219\u201345. https:\/\/doi.org\/10.1016\/bs.mie.2015.03.011. [cited 2026 Jun 30].","journal-title":"Methods Enzymol"},{"key":"2749_CR196","doi-asserted-by":"publisher","unstructured":"Barozzi C, Zacchini F, Corradini AG, Morara M, Serra M, De Sanctis V, et al. Alterations of ribosomal RNA pseudouridylation in human breast cancer. NAR Cancer. 2023;5. https:\/\/doi.org\/10.1093\/NARCAN\/ZCAD026. [cited 2026 Jun 30].","DOI":"10.1093\/NARCAN\/ZCAD026"},{"key":"2749_CR197","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1080\/15476286.2021.1974750","volume":"18","author":"Y Motorin","year":"2021","unstructured":"Motorin Y, Quinternet M, Rhalloussi W, Marchand V. Constitutive and variable 2\u2019-O-methylation (Nm) in human ribosomal RNA. RNA Biol. 2021;18:88\u201397. https:\/\/doi.org\/10.1080\/15476286.2021.1974750. [cited 2026 Apr 28].","journal-title":"RNA Biol"},{"key":"2749_CR198","doi-asserted-by":"publisher","DOI":"10.1093\/NARCAN\/ZCAA036","author":"V Marcel","year":"2020","unstructured":"Marcel V, Kielbassa J, Marchand V, Natchiar KS, Paraqindes H, Van Nguyen F, et al. Ribosomal RNA 2\u2019O-methylation as a novel layer of inter-tumour heterogeneity in breast cancer. NAR Cancer. 2020. https:\/\/doi.org\/10.1093\/NARCAN\/ZCAA036. [cited 2026 Apr 6]. 2.","journal-title":"NAR Cancer"},{"key":"2749_CR199","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1016\/j.devcel.2023.06.007","volume":"58","author":"SJ H\u00e4fner","year":"2023","unstructured":"H\u00e4fner SJ, Jansson MD, Altinel K, Andersen KL, Abay-N\u00f8rgaard Z, M\u00e9nard P, et al. Ribosomal RNA 2\u2032-O-methylation dynamics impact cell fate decisions. Dev Cell. 2023;58:1593\u2013609. https:\/\/doi.org\/10.1016\/j.devcel.2023.06.007. .e9.","journal-title":"Dev Cell"},{"key":"2749_CR200","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.ccr.2013.08.013","volume":"24","author":"V Marcel","year":"2013","unstructured":"Marcel V, Ghayad SE, Belin S, Therizols G, Morel AP, Solano-Gonz\u00e0lez E, et al. P53 Acts as a Safeguard of Translational Control by Regulating Fibrillarin and rRNA Methylation in Cancer. Cancer Cell. 2013;24:318\u201330. https:\/\/doi.org\/10.1016\/j.ccr.2013.08.013. [cited 2026 Apr 6].","journal-title":"Cancer Cell"},{"key":"2749_CR201","doi-asserted-by":"publisher","first-page":"12934","DOI":"10.1073\/PNAS.1707674114","volume":"114","author":"J Erales","year":"2017","unstructured":"Erales J, Marchand V, Panthu B, Gillot S, Belin S, Ghayad SE, et al. Evidence for rRNA 2\u2019-O-methylation plasticity: Control of intrinsic translational capabilities of human ribosomes. Proc Natl Acad Sci U S A. 2017;114:12934\u20139. https:\/\/doi.org\/10.1073\/PNAS.1707674114. [cited 2026 Apr 6].","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2749_CR202","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/NATURE24482","volume":"551","author":"SK Natchiar","year":"2017","unstructured":"Natchiar SK, Myasnikov AG, Kratzat H, Hazemann I, Klaholz BP. Visualization of chemical modifications in the human 80S ribosome structure. Nat Nat. 2017;551:472\u20137. https:\/\/doi.org\/10.1038\/NATURE24482. [cited 2026 Apr 6].","journal-title":"Nat Nat"},{"key":"2749_CR203","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/S41556-021-00653-6","volume":"23","author":"Y Yi","year":"2021","unstructured":"Yi Y, Li Y, Meng Q, Li Q, Li F, Lu B, et al. A PRC2-independent function for EZH2 in regulating rRNA 2\u2019-O methylation and IRES-dependent translation. Nat Cell Biol. 2021;23:341\u201354. https:\/\/doi.org\/10.1038\/S41556-021-00653-6. [cited 2026 Apr 6].","journal-title":"Nat Cell Biol"},{"key":"2749_CR204","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/NG0598-32","volume":"19","author":"NS Heiss","year":"1998","unstructured":"Heiss NS, Knight SW, Vulliamy TJ, Klauck SM, Wiemann S, Mason PJ, et al. X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions. Nat Genet. 1998;19:32\u20138. https:\/\/doi.org\/10.1038\/NG0598-32. [cited 2026 Apr 6].","journal-title":"Nat Genet"},{"key":"2749_CR205","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1126\/SCIENCE.1123835","volume":"312","author":"A Yoon","year":"2006","unstructured":"Yoon A, Peng G, Brandenburg Y, Zollo O, Xu W, Rego E, et al. Impaired control of IRES-mediated translation in X-linked dyskeratosis congenita. Science. 2006;312:902\u20136. https:\/\/doi.org\/10.1126\/SCIENCE.1123835. [cited 2026 Apr 6].","journal-title":"Science"},{"key":"2749_CR206","doi-asserted-by":"publisher","first-page":"6026","DOI":"10.1158\/0008-5472.CAN-09-4730","volume":"70","author":"C Bellodi","year":"2010","unstructured":"Bellodi C, Krasnykh O, Haynes N, Theodoropoulou M, Peng G, Montanaro L, et al. Loss of function of the tumor suppressor DKC1 perturbs p27 translation control and contributes to pituitary tumorigenesis. Cancer Res. 2010;70:6026\u201335. https:\/\/doi.org\/10.1158\/0008-5472.CAN-09-4730. [cited 2026 Apr 6].","journal-title":"Cancer Res"},{"key":"2749_CR207","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/NATURE10165","volume":"474","author":"J Karijolich","year":"2011","unstructured":"Karijolich J, Yu YT. Converting nonsense codons into sense codons by targeted pseudouridylation. Nature. 2011;474:395\u20139. https:\/\/doi.org\/10.1038\/NATURE10165. [cited 2026 Apr 6].","journal-title":"Nature"},{"key":"2749_CR208","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/990141","volume":"402","author":"JR Mitchell","year":"1999","unstructured":"Mitchell JR, Wood E, Collins K. A telomerase component is defective in the human disease dyskeratosis congenita. Nature. 1999;402:551\u20135. https:\/\/doi.org\/10.1038\/990141. [cited 2026 Apr 6].","journal-title":"Nature"},{"key":"2749_CR209","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.molcel.2011.09.017","volume":"44","author":"K Jack","year":"2011","unstructured":"Jack K, Bellodi C, Landry DM, Niederer RO, Meskauskas A, Musalgaonkar S, et al. RRNA Pseudouridylation Defects Affect Ribosomal Ligand Binding and Translational Fidelity from Yeast to Human Cells. Mol Cell. 2011;44:660\u20136. https:\/\/doi.org\/10.1016\/j.molcel.2011.09.017. [cited 2026 Apr 6].","journal-title":"Mol Cell"},{"key":"2749_CR210","doi-asserted-by":"publisher","first-page":"26201","DOI":"10.1074\/jbc.M114.593996","volume":"289","author":"S Ito","year":"2014","unstructured":"Ito S, Akamatsu Y, Noma A, Kimura S, Miyauchi K, Ikeuchi Y, et al. A single acetylation of 18 S rRNA is essential for biogenesis of the small ribosomal subunit in saccharomyces cerevisiae. J Biol Chem. 2014;289:26201\u201312. https:\/\/doi.org\/10.1074\/jbc.M114.593996. [cited 2026 Apr 6].","journal-title":"J Biol Chem"},{"key":"2749_CR211","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1038\/NCB3563","volume":"19","author":"F Zhou","year":"2017","unstructured":"Zhou F, Liu Y, Rohde C, Pauli C, Gerloff D, K\u00f6hn M, et al. AML1-ETO requires enhanced C\/D box snoRNA\/RNP formation to induce self-renewal and leukaemia. Nat Cell Biol. 2017;19:844\u201355. https:\/\/doi.org\/10.1038\/NCB3563. [cited 2026 Apr 6].","journal-title":"Nat Cell Biol"},{"key":"2749_CR212","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1038\/LEU.2012.111","volume":"26","author":"W Valleron","year":"2012","unstructured":"Valleron W, Laprevotte E, Gautier EF, Quelen C, Demur C, Delabesse E, et al. Specific small nucleolar RNA expression profiles in acute leukemia. Leukemia. 2012;26:2052\u201360. https:\/\/doi.org\/10.1038\/LEU.2012.111. [cited 2026 Apr 6].","journal-title":"Leukemia"},{"key":"2749_CR213","doi-asserted-by":"publisher","unstructured":"Falaleeva M, Welden JR, Duncan MJ, Stamm S. C\/D-box snoRNAs form methylating and non-methylating ribonucleoprotein complexes: Old dogs show new tricks. BioEssays. 2017;39. https:\/\/doi.org\/10.1002\/BIES.201600264. [cited 2026 Apr 6].","DOI":"10.1002\/BIES.201600264"},{"key":"2749_CR214","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.cmet.2015.08.024","volume":"22","author":"SJ Mentch","year":"2015","unstructured":"Mentch SJ, Mehrmohamadi M, Huang L, Liu X, Gupta D, Mattocks D, et al. Histone Methylation Dynamics and Gene Regulation Occur through the Sensing of One-Carbon Metabolism. Cell Metab. 2015;22:861\u201373. https:\/\/doi.org\/10.1016\/j.cmet.2015.08.024. [cited 2026 Apr 6].","journal-title":"Cell Metab"},{"key":"2749_CR215","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/S41580-021-00342-0","volume":"22","author":"T Suzuki","year":"2021","unstructured":"Suzuki T. The expanding world of tRNA modifications and their disease relevance. Nat Rev Mol Cell Biol. 2021;22:375\u201392. https:\/\/doi.org\/10.1038\/S41580-021-00342-0. [cited 2026 Apr 6].","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2749_CR216","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/NRM.2017.77","volume":"19","author":"P Schimmel","year":"2018","unstructured":"Schimmel P. The emerging complexity of the tRNA world: mammalian tRNAs beyond protein synthesis. Nat Rev Mol Cell Biol. 2018;19:45\u201358. https:\/\/doi.org\/10.1038\/NRM.2017.77. [cited 2026 Apr 6].","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2749_CR217","doi-asserted-by":"publisher","unstructured":"Buschauer R, Matsuo Y, Sugiyama T, Chen YH, Alhusaini N, Sweet T, et al. The Ccr4-Not complex monitors the translating ribosome for codon optimality. Science. 2020;368. https:\/\/doi.org\/10.1126\/SCIENCE.AAY6912. [cited 2026 Apr 6].","DOI":"10.1126\/SCIENCE.AAY6912"},{"key":"2749_CR218","doi-asserted-by":"publisher","first-page":"3422","DOI":"10.1016\/j.ymthe.2021.08.005","volume":"29","author":"J Ma","year":"2021","unstructured":"Ma J, Han H, Huang Y, Yang C, Zheng S, Cai T, et al. METTL1\/WDR4-mediated m7G tRNA modifications and m7G codon usage promote mRNA translation and lung cancer progression. Mol Ther. 2021;29:3422\u201335. https:\/\/doi.org\/10.1016\/j.ymthe.2021.08.005. [cited 2026 Apr 6].","journal-title":"Mol Ther"},{"key":"2749_CR219","doi-asserted-by":"publisher","first-page":"3339","DOI":"10.1016\/J.MOLCEL.2021.07.003","volume":"81","author":"Z Dai","year":"2021","unstructured":"Dai Z, Liu H, Liao J, Huang C, Ren X, Zhu W, et al. N7-Methylguanosine tRNA modification enhances oncogenic mRNA translation and promotes intrahepatic cholangiocarcinoma progression. Mol Cell. 2021;81:3339\u2013e33558. https:\/\/doi.org\/10.1016\/J.MOLCEL.2021.07.003. [cited 2026 Apr 6].","journal-title":"Mol Cell"},{"key":"2749_CR220","doi-asserted-by":"publisher","unstructured":"Han H, Yang C, Ma J, Zhang S, Zheng S, Ling R, et al. N7-methylguanosine tRNA modification promotes esophageal squamous cell carcinoma tumorigenesis via the RPTOR\/ULK1\/autophagy axis. Nat Commun. 2022;13. https:\/\/doi.org\/10.1038\/S41467-022-29125-7. [cited 2026 Apr 6].","DOI":"10.1038\/S41467-022-29125-7"},{"key":"2749_CR221","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1038\/S41388-023-02695-6","volume":"42","author":"Z Wang","year":"2023","unstructured":"Wang Z, Yu P, Zou Y, Ma J, Han H, Wei W, et al. METTL1\/WDR4-mediated tRNA m7G modification and mRNA translation control promote oncogenesis and doxorubicin resistance. Oncogene. 2023;42:1900\u201312. https:\/\/doi.org\/10.1038\/S41388-023-02695-6. [cited 2026 Apr 6].","journal-title":"Oncogene"},{"key":"2749_CR222","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/S41586-022-05565-5","volume":"613","author":"VM Ruiz-Arroyo","year":"2023","unstructured":"Ruiz-Arroyo VM, Raj R, Babu K, Onolbaatar O, Roberts PH, Nam Y. Structures and mechanisms of tRNA methylation by METTL1-WDR4. Nature. 2023;613:383\u201390. https:\/\/doi.org\/10.1038\/S41586-022-05565-5. [cited 2026 Apr 6].","journal-title":"Nature"},{"key":"2749_CR223","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/S41586-022-05566-4","volume":"613","author":"J Li","year":"2023","unstructured":"Li J, Wang L, Hahn Q, Nowak RP, Viennet T, Orellana EA, et al. Structural basis of regulated m7G tRNA modification by METTL1-WDR4. Nature. 2023;613:391\u20137. https:\/\/doi.org\/10.1038\/S41586-022-05566-4. [cited 2026 Apr 6].","journal-title":"Nature"},{"key":"2749_CR224","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/NATURE24456","volume":"551","author":"M Safra","year":"2017","unstructured":"Safra M, Sas-Chen A, Nir R, Winkler R, Nachshon A, Bar-Yaacov D, et al. The m1A landscape on cytosolic and mitochondrial mRNA at single-base resolution. Nature. 2017;551:251\u20135. https:\/\/doi.org\/10.1038\/NATURE24456. [cited 2026 Apr 6].","journal-title":"Nature"},{"key":"2749_CR225","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1261\/RNA.035600.112","volume":"18","author":"T Chujo","year":"2012","unstructured":"Chujo T, Suzuki T. Trmt61B is a methyltransferase responsible for 1-methyladenosine at position 58 of human mitochondrial tRNAs. RNA. 2012;18:2269\u201376. https:\/\/doi.org\/10.1261\/RNA.035600.112. [cited 2026 Apr 6].","journal-title":"RNA"},{"key":"2749_CR226","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/S41586-018-0243-7","volume":"558","author":"F Rapino","year":"2018","unstructured":"Rapino F, Delaunay S, Rambow F, Zhou Z, Tharun L, De Tullio P, et al. Codon-specific translation reprogramming promotes resistance to targeted therapy. Nature. 2018;558:605\u20139. https:\/\/doi.org\/10.1038\/S41586-018-0243-7. [cited 2026 Apr 6].","journal-title":"Nature"},{"key":"2749_CR227","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.15252\/EMBJ.201489282","volume":"33","author":"S Blanco","year":"2014","unstructured":"Blanco S, Dietmann S, Flores JV, Hussain S, Kutter C, Humphreys P, et al. Aberrant methylation of tRNAs links cellular stress to neuro-developmental disorders. EMBO J. 2014;33:2020\u201339. https:\/\/doi.org\/10.15252\/EMBJ.201489282. [cited 2026 Apr 6].","journal-title":"EMBO J"},{"key":"2749_CR228","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/j.cell.2015.02.029","volume":"160","author":"V Presnyak","year":"2015","unstructured":"Presnyak V, Alhusaini N, Chen YH, Martin S, Morris N, Kline N, et al. Codon optimality is a major determinant of mRNA stability. Cell. 2015;160:1111\u201324. https:\/\/doi.org\/10.1016\/j.cell.2015.02.029. [cited 2026 Apr 6].","journal-title":"Cell"},{"key":"2749_CR229","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.molcel.2015.07.018","volume":"59","author":"CH Yu","year":"2015","unstructured":"Yu CH, Dang Y, Zhou Z, Wu C, Zhao F, Sachs MS, et al. Codon Usage Influences the Local Rate of Translation Elongation to Regulate Co-translational Protein Folding. Mol Cell. 2015;59:744\u201354. https:\/\/doi.org\/10.1016\/j.molcel.2015.07.018. [cited 2026 Apr 6].","journal-title":"Mol Cell"},{"key":"2749_CR230","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.molcel.2018.08.037","volume":"72","author":"S Juszkiewicz","year":"2018","unstructured":"Juszkiewicz S, Chandrasekaran V, Lin Z, Kraatz S, Ramakrishnan V, Hegde RS. ZNF598 Is a Quality Control Sensor of Collided Ribosomes. Mol Cell. 2018;72:469\u201381. https:\/\/doi.org\/10.1016\/j.molcel.2018.08.037. [cited 2026 Apr 6]. .e7.","journal-title":"Mol Cell"},{"key":"2749_CR231","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/j.cell.2014.08.011","volume":"158","author":"H Gingold","year":"2014","unstructured":"Gingold H, Tehler D, Christoffersen NR, Nielsen MM, Asmar F, Kooistra SM, et al. A dual program for translation regulation in cellular proliferation and differentiation. Cell. 2014;158:1281\u201392. https:\/\/doi.org\/10.1016\/j.cell.2014.08.011. [cited 2026 Apr 6].","journal-title":"Cell"},{"key":"2749_CR232","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/NATURE01327","volume":"421","author":"N Gomez-Roman","year":"2003","unstructured":"Gomez-Roman N, Grandori C, Eisenman RN, White RJ. Direct activation of RNA polymerase III transcription by c-Myc. Nature. 2003;421:290\u20134. https:\/\/doi.org\/10.1038\/NATURE01327. [cited 2026 Apr 6].","journal-title":"Nature"},{"key":"2749_CR233","doi-asserted-by":"publisher","first-page":"7268","DOI":"10.1093\/NAR\/GKP787","volume":"37","author":"M Pavon-Eternod","year":"2009","unstructured":"Pavon-Eternod M, Gomes S, Geslain R, Dai Q, Rosner MR, Pan T. tRNA over-expression in breast cancer and functional consequences. Nucleic Acids Res. 2009;37:7268\u201380. https:\/\/doi.org\/10.1093\/NAR\/GKP787. [cited 2026 Apr 6].","journal-title":"Nucleic Acids Res"},{"key":"2749_CR234","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/J.MOLCEL.2011.06.022","volume":"43","author":"P Ivanov","year":"2011","unstructured":"Ivanov P, Emara MM, Villen J, Gygi SP, Anderson P. Angiogenin-induced tRNA fragments inhibit translation initiation. Mol Cell. 2011;43:613\u201323. https:\/\/doi.org\/10.1016\/J.MOLCEL.2011.06.022. [cited 2026 Apr 6].","journal-title":"Mol Cell"},{"key":"2749_CR235","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1083\/JCB.200811106","volume":"185","author":"S Yamasaki","year":"2009","unstructured":"Yamasaki S, Ivanov P, Hu GF, Anderson P. Angiogenin cleaves tRNA and promotes stress-induced translational repression. J Cell Biol. 2009;185:35\u201342. https:\/\/doi.org\/10.1083\/JCB.200811106. [cited 2026 Apr 6].","journal-title":"J Cell Biol"},{"key":"2749_CR236","doi-asserted-by":"publisher","unstructured":"Kumar P, Anaya J, Mudunuri SB, Dutta A. Meta-analysis of tRNA derived RNA fragments reveals that they are evolutionarily conserved and associate with AGO proteins to recognize specific RNA targets. BMC Biol. 2014;12. https:\/\/doi.org\/10.1186\/S12915-014-0078-0. [cited 2026 Apr 6].","DOI":"10.1186\/S12915-014-0078-0"},{"key":"2749_CR237","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.cell.2015.02.053","volume":"161","author":"H Goodarzi","year":"2015","unstructured":"Goodarzi H, Liu X, Nguyen HCB, Zhang S, Fish L, Tavazoie SF. Endogenous tRNA-derived fragments suppress breast cancer progression via YBX1 displacement. Cell. 2015;161:790\u2013802. https:\/\/doi.org\/10.1016\/j.cell.2015.02.053. [cited 2026 Apr 6].","journal-title":"Cell"},{"key":"2749_CR238","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1038\/NSMB.2357","volume":"19","author":"F Tuorto","year":"2012","unstructured":"Tuorto F, Liebers R, Musch T, Schaefer M, Hofmann S, Kellner S, et al. RNA cytosine methylation by Dnmt2 and NSun2 promotes tRNA stability and protein synthesis. Nat Struct Mol Biol. 2012;19:900\u20135. https:\/\/doi.org\/10.1038\/NSMB.2357. [cited 2026 Apr 6].","journal-title":"Nat Struct Mol Biol"},{"key":"2749_CR239","doi-asserted-by":"publisher","unstructured":"Garc\u00eda-V\u00edlchez R, A\u00f1azco-Guenkova AM, Dietmann S, L\u00f3pez J, Mor\u00f3n-Calvente V, D\u2019Ambrosi S, et al. METTL1 promotes tumorigenesis through tRNA-derived fragment biogenesis in prostate cancer. Mol Cancer. 2023;22. https:\/\/doi.org\/10.1186\/S12943-023-01809-8. [cited 2026 Apr 6].","DOI":"10.1186\/S12943-023-01809-8"},{"key":"2749_CR240","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/NCHEMBIO.1158","volume":"9","author":"M Paul","year":"2013","unstructured":"Paul M, Schimmel P. Essential nontranslational functions of tRNA synthetases. Nat Chem Biol. 2013;9:145\u201353. https:\/\/doi.org\/10.1038\/NCHEMBIO.1158. [cited 2026 Apr 6].","journal-title":"Nat Chem Biol"},{"key":"2749_CR241","doi-asserted-by":"crossref","unstructured":"Dameshek W. Riddle: what do aplastic anemia, paroxysmal nocturnal hemoglobinuria (PNH) and \u2018hypoplastic\u2019 leukemia have in common? - PubMed. Blood. 1967;2:251\u20134. https:\/\/pubmed.ncbi.nlm.nih.gov\/6031145\/. Accessed 29 Jun 2026. [cited 2026 Jun 29].","DOI":"10.1182\/blood.V30.2.251.251"},{"key":"2749_CR242","doi-asserted-by":"publisher","first-page":"3815","DOI":"10.1182\/BLOOD-2011-08-375972","volume":"119","author":"A Vlachos","year":"2012","unstructured":"Vlachos A, Rosenberg PS, Atsidaftos E, Alter BP, Lipton JM. Incidence of neoplasia in Diamond Blackfan anemia: a report from the Diamond Blackfan Anemia Registry. Blood. 2012;119:3815\u20139. https:\/\/doi.org\/10.1182\/BLOOD-2011-08-375972. [cited 2026 Apr 6].","journal-title":"Blood"},{"key":"2749_CR243","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1242\/DMM.020529","volume":"8","author":"N Danilova","year":"2015","unstructured":"Danilova N, Gazda HT. Ribosomopathies: how a common root can cause a tree of pathologies. Dis Model Mech. 2015;8:1013\u201326. https:\/\/doi.org\/10.1242\/DMM.020529. [cited 2026 Apr 6].","journal-title":"Dis Model Mech"},{"key":"2749_CR244","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1158\/2159-8290.CD-17-0550","volume":"7","author":"SO Sulima","year":"2017","unstructured":"Sulima SO, Hofman IJF, De Keersmaecker K, Dinman JD. How Ribosomes Translate Cancer. Cancer Discov. 2017;7:1069\u201387. https:\/\/doi.org\/10.1158\/2159-8290.CD-17-0550. [cited 2026 Apr 6].","journal-title":"Cancer Discov"},{"key":"2749_CR245","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1093\/NAR\/GKZ637","volume":"48","author":"KR Kampen","year":"2020","unstructured":"Kampen KR, Sulima SO, Vereecke S, de Keersmaecker K. Hallmarks of ribosomopathies. Nucleic Acids Res. 2020;48:1013\u201328. https:\/\/doi.org\/10.1093\/NAR\/GKZ637. [cited 2026 Apr 6].","journal-title":"Nucleic Acids Res"},{"key":"2749_CR246","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/5951","volume":"21","author":"N Draptchinskaia","year":"1999","unstructured":"Draptchinskaia N, Gustavsson P, Andersson B, Pettersson M, Willig TN, Dianzani I, et al. The gene encoding ribosomal protein S19 is mutated in Diamond-Blackfan anaemia. Nat Genet. 1999;21:169\u201375. https:\/\/doi.org\/10.1038\/5951. [cited 2026 Apr 6].","journal-title":"Nat Genet"},{"key":"2749_CR247","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.ajhg.2008.11.004","volume":"83","author":"HT Gazda","year":"2008","unstructured":"Gazda HT, Sheen MR, Vlachos A, Choesmel V, O\u2019Donohue MF, Schneider H, et al. Ribosomal Protein L5 and L11 Mutations Are Associated with Cleft Palate and Abnormal Thumbs in Diamond-Blackfan Anemia Patients. Am J Hum Genet. 2008;83:769\u201380. https:\/\/doi.org\/10.1016\/j.ajhg.2008.11.004. [cited 2026 Apr 6].","journal-title":"Am J Hum Genet"},{"key":"2749_CR248","doi-asserted-by":"publisher","unstructured":"van Dooijeweert B, Kia SK, Dahl N, Fenneteau O, Leguit R, Nieuwenhuis E, et al. GATA-1 Defects in Diamond-Blackfan Anemia: Phenotypic Characterization Points to a Specific Subset of Disease. Genes (Basel). 2022;13. https:\/\/doi.org\/10.3390\/GENES13030447. [cited 2026 Jun 30].","DOI":"10.3390\/GENES13030447"},{"key":"2749_CR249","doi-asserted-by":"publisher","first-page":"2567","DOI":"10.1182\/BLOOD-2010-07-295238","volume":"117","author":"S Dutt","year":"2011","unstructured":"Dutt S, Narla A, Lin K, Mullally A, Abayasekara N, Megerdichian C, et al. Haploinsufficiency for ribosomal protein genes causes selective activation of p53 in human erythroid progenitor cells. Blood. 2011;117:2567\u201376. https:\/\/doi.org\/10.1182\/BLOOD-2010-07-295238. [cited 2026 Apr 6].","journal-title":"Blood"},{"key":"2749_CR250","doi-asserted-by":"publisher","first-page":"4253","DOI":"10.1038\/ONC.2010.189","volume":"29","author":"C Deisenroth","year":"2010","unstructured":"Deisenroth C, Zhang Y. Ribosome biogenesis surveillance: probing the ribosomal protein-Mdm2-p53 pathway. Oncogene. 2010;29:4253\u201360. https:\/\/doi.org\/10.1038\/ONC.2010.189. [cited 2026 Apr 6].","journal-title":"Oncogene"},{"key":"2749_CR251","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/J.CELL.2018.02.036","volume":"173","author":"RK Khajuria","year":"2018","unstructured":"Khajuria RK, Munschauer M, Ulirsch JC, Fiorini C, Ludwig LS, McFarland SK, et al. Ribosome Levels Selectively Regulate Translation and Lineage Commitment in Human Hematopoiesis. Cell. 2018;173:90\u2013103. https:\/\/doi.org\/10.1016\/J.CELL.2018.02.036. [cited 2026 Apr 6]. .e19.","journal-title":"Cell"},{"key":"2749_CR252","doi-asserted-by":"publisher","unstructured":"Mills EW, Green R, Ribosomopathies. There\u2019s strength in numbers. Science. 2017;358. https:\/\/doi.org\/10.1126\/SCIENCE.AAN2755. [cited 2026 Apr 6].","DOI":"10.1126\/SCIENCE.AAN2755"},{"key":"2749_CR253","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1038\/NM.3557","volume":"20","author":"LS Ludwig","year":"2014","unstructured":"Ludwig LS, Gazda HT, Eng JC, Eichhorn SW, Thiru P, Ghazvinian R, et al. Altered translation of GATA1 in Diamond-Blackfan anemia. Nat Med. 2014;20:748\u201353. https:\/\/doi.org\/10.1038\/NM.3557. [cited 2026 Apr 6].","journal-title":"Nat Med"},{"key":"2749_CR254","doi-asserted-by":"publisher","unstructured":"Wang B, Wang C, Wan Y, Gao J, Ma Y, Zhang Y, et al. Decoding the pathogenesis of Diamond-Blackfan anemia using single-cell RNA-seq. Cell Discov. 2022;8. https:\/\/doi.org\/10.1038\/S41421-022-00389-Z. [cited 2026 Apr 6].","DOI":"10.1038\/S41421-022-00389-Z"},{"key":"2749_CR255","doi-asserted-by":"publisher","unstructured":"Lorenzo-Mart\u00edn LF, Robles-Valero J, Ram\u00edrez-Cota R, Gaspar SG, Fuentes P, Gentilella A, et al. Ribosomal protein deficiencies linked to Diamond-Blackfan anemia induce distinctive alterations of ATF4 expression. iScience. 2025;28. https:\/\/doi.org\/10.1016\/j.isci.2025.112138. [cited 2026 Apr 6].","DOI":"10.1016\/j.isci.2025.112138"},{"key":"2749_CR256","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.hoc.2009.01.004","volume":"23","author":"JM Lipton","year":"2009","unstructured":"Lipton JM, Ellis SR. Diamond-Blackfan Anemia: Diagnosis, Treatment, and Molecular Pathogenesis. Hematol Oncol Clin North Am. 2009;23:261\u201382. https:\/\/doi.org\/10.1016\/j.hoc.2009.01.004. [cited 2026 Apr 6].","journal-title":"Hematol Oncol Clin North Am"},{"key":"2749_CR257","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/NRC.2016.112","volume":"17","author":"AS Sperling","year":"2017","unstructured":"Sperling AS, Gibson CJ, Ebert BL. The genetics of myelodysplastic syndrome: from clonal haematopoiesis to secondary leukaemia. Nat Rev Cancer. 2017;17:5\u201319. https:\/\/doi.org\/10.1038\/NRC.2016.112. [cited 2026 Apr 6].","journal-title":"Nat Rev Cancer"},{"key":"2749_CR258","doi-asserted-by":"publisher","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","volume":"371","author":"S Jaiswal","year":"2014","unstructured":"Jaiswal S, Fontanillas P, Flannick J, Manning A, Grauman PV, Mar BG, et al. Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes. N Engl J Med. 2014;371:2488\u201398. https:\/\/doi.org\/10.1056\/NEJMoa1408617.","journal-title":"N Engl J Med"},{"key":"2749_CR259","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.cell.2022.11.001","volume":"186","author":"C L\u00f3pez-Ot\u00edn","year":"2023","unstructured":"L\u00f3pez-Ot\u00edn C, Blasco MA, Partridge L, Serrano M, Kroemer G. Hallmarks of aging: An expanding universe. Cell. 2023;186:243\u201378. https:\/\/doi.org\/10.1016\/j.cell.2022.11.001. [cited 2026 Apr 6].","journal-title":"Cell"},{"key":"2749_CR260","doi-asserted-by":"publisher","unstructured":"Dokal I. Dyskeratosis congenita. Hematology Am Soc Hematol Educ Program. 2011;2011:480\u20136. https:\/\/doi.org\/10.1182\/ASHEDUCATION-2011.1.480. [cited 2026 Apr 6].","DOI":"10.1182\/ASHEDUCATION-2011.1.480"},{"key":"2749_CR261","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/S00412-005-0333-9","volume":"114","author":"UT Meier","year":"2005","unstructured":"Meier UT. The many facets of H\/ACA ribonucleoproteins. Chromosoma. 2005;114:1\u201314. https:\/\/doi.org\/10.1007\/S00412-005-0333-9. [cited 2026 Apr 6].","journal-title":"Chromosoma"},{"key":"2749_CR262","doi-asserted-by":"publisher","first-page":"21755","DOI":"10.18632\/ONCOTARGET.4580","volume":"6","author":"M Penzo","year":"2015","unstructured":"Penzo M, Ludovini V, Trer\u00e9 D, Siggillino A, Vannucci J, Bellezza G, et al. Dyskerin and TERC expression may condition survival in lung cancer patients. Oncotarget. 2015;6:21755\u201360. https:\/\/doi.org\/10.18632\/ONCOTARGET.4580. [cited 2026 Jun 30].","journal-title":"Oncotarget"},{"key":"2749_CR263","doi-asserted-by":"publisher","first-page":"2680","DOI":"10.1182\/BLOOD-2005-07-2622","volume":"107","author":"TJ Vulliamy","year":"2006","unstructured":"Vulliamy TJ, Marrone A, Knight SW, Walne A, Mason PJ, Dokal I. Mutations in dyskeratosis congenita: their impact on telomere length and the diversity of clinical presentation. Blood. 2006;107:2680\u20135. https:\/\/doi.org\/10.1182\/BLOOD-2005-07-2622. [cited 2026 Apr 6].","journal-title":"Blood"},{"key":"2749_CR264","doi-asserted-by":"publisher","first-page":"8308","DOI":"10.1093\/NAR\/GKT587","volume":"41","author":"L Rocchi","year":"2013","unstructured":"Rocchi L, Pacilli A, Sethi R, Penzo M, Schneider RJ, Trer\u00e9 D, et al. Dyskerin depletion increases VEGF mRNA internal ribosome entry site-mediated translation. Nucleic Acids Res. 2013;41:8308. https:\/\/doi.org\/10.1093\/NAR\/GKT587. [cited 2026 Jun 30].","journal-title":"Nucleic Acids Res"},{"key":"2749_CR265","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/S0022-3476(64)80150-5","volume":"65","author":"H Shwachman","year":"1964","unstructured":"Shwachman H, Diamond LK, Oski FA, Khaw KT. The syndrome of pancreatic insufficiency and bone marrow dysfunction. J Pediatr. 1964;65:645\u201363. https:\/\/doi.org\/10.1016\/S0022-3476(64)80150-5. [cited 2026 Apr 6].","journal-title":"J Pediatr"},{"key":"2749_CR266","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/J.1749-6632.2011.06349.X","volume":"1242","author":"Y Dror","year":"2011","unstructured":"Dror Y, Donadieu J, Koglmeier J, Dodge J, Toiviainen-Salo S, Makitie O, et al. Draft consensus guidelines for diagnosis and treatment of Shwachman-Diamond syndrome. Ann N Y Acad Sci. 2011;1242:40\u201355. https:\/\/doi.org\/10.1111\/J.1749-6632.2011.06349.X. [cited 2026 Apr 6].","journal-title":"Ann N Y Acad Sci"},{"key":"2749_CR267","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/NG1062","volume":"33","author":"GRB Boocock","year":"2003","unstructured":"Boocock GRB, Morrison JA, Popovic M, Richards N, Ellis L, Durie PR, et al. Mutations in SBDS are associated with Shwachman-Diamond syndrome. Nat Genet. 2003;33:97\u2013101. https:\/\/doi.org\/10.1038\/NG1062. [cited 2026 Apr 6].","journal-title":"Nat Genet"},{"key":"2749_CR268","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/NG1994","volume":"39","author":"TF Menne","year":"2007","unstructured":"Menne TF, Goyenechea B, S\u00e1nchez-Puig N, Wong CC, Tonkin LM, Ancliff PJ, et al. The Shwachman-Bodian-Diamond syndrome protein mediates translational activation of ribosomes in yeast. Nat Genet. 2007;39:486\u201395. https:\/\/doi.org\/10.1038\/NG1994. [cited 2026 Apr 6].","journal-title":"Nat Genet"},{"key":"2749_CR269","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1038\/NSMB.3112","volume":"22","author":"F Weis","year":"2015","unstructured":"Weis F, Giudice E, Churcher M, Jin L, Hilcenko C, Wong CC, et al. Mechanism of eIF6 release from the nascent 60S ribosomal subunit. Nat Struct Mol Biol. 2015;22:914\u20139. https:\/\/doi.org\/10.1038\/NSMB.3112. [cited 2026 Apr 6].","journal-title":"Nat Struct Mol Biol"},{"key":"2749_CR270","doi-asserted-by":"publisher","first-page":"4305","DOI":"10.1182\/BLOOD-2011-06-353938","volume":"118","author":"CC Wong","year":"2011","unstructured":"Wong CC, Traynor D, Basse N, Kay RR, Warren AJ. Defective ribosome assembly in Shwachman-Diamond syndrome. Blood. 2011;118:4305\u201312. https:\/\/doi.org\/10.1182\/BLOOD-2011-06-353938. [cited 2026 Apr 6].","journal-title":"Blood"},{"key":"2749_CR271","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/J.STEM.2016.08.021","volume":"19","author":"NA Zambetti","year":"2016","unstructured":"Zambetti NA, Ping Z, Chen S, Kenswil KJG, Mylona MA, Sanders MA, et al. Mesenchymal Inflammation Drives Genotoxic Stress in Hematopoietic Stem Cells and Predicts Disease Evolution in Human Pre-leukemia. Cell Stem Cell. 2016;19:613\u201327. https:\/\/doi.org\/10.1016\/J.STEM.2016.08.021. [cited 2026 Apr 6].","journal-title":"Cell Stem Cell"},{"key":"2749_CR272","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1182\/BLOOD.2022017739","volume":"141","author":"CR Reilly","year":"2023","unstructured":"Reilly CR, Shimamura A. Predisposition to myeloid malignancies in Shwachman-Diamond syndrome: biological insights and clinical advances. Blood. 2023;141:1513\u201323. https:\/\/doi.org\/10.1182\/BLOOD.2022017739. [cited 2026 Apr 6].","journal-title":"Blood"},{"key":"2749_CR273","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.3324\/HAEMATOL.2015.131573","volume":"100","author":"NA Zambetti","year":"2015","unstructured":"Zambetti NA, Bindels EMJ, Van Strien PMH, Valkhof MG, Adisty MN, Hoogenboezem RM, et al. Deficiency of the ribosome biogenesis gene Sbds in hematopoietic stem and progenitor cells causes neutropenia in mice by attenuating lineage progression in myelocytes. Haematologica. 2015;100:1285. https:\/\/doi.org\/10.3324\/HAEMATOL.2015.131573. [cited 2026 Apr 6].","journal-title":"Haematologica"},{"key":"2749_CR274","doi-asserted-by":"publisher","first-page":"4134","DOI":"10.1093\/NAR\/GKW005","volume":"44","author":"K In","year":"2016","unstructured":"In K, Zaini MA, M\u00fcller C, Warren AJ, Von Lindern M, Calkhoven CF. Shwachman-Bodian-Diamond syndrome (SBDS) protein deficiency impairs translation re-initiation from C\/EBP\u03b1 and C\/EBP\u03b2 mRNAs. Nucleic Acids Res. 2016;44:4134\u201346. https:\/\/doi.org\/10.1093\/NAR\/GKW005. [cited 2026 Apr 28].","journal-title":"Nucleic Acids Res"},{"key":"2749_CR275","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1053\/j.seminhematol.2011.01.002","volume":"48","author":"N Burwick","year":"2011","unstructured":"Burwick N, Shimamura A, Liu JM. Non-diamond Blackfan anemia disorders of ribosome function: Shwachman diamond syndrome and 5q- syndrome. Semin Hematol. 2011;48:136\u201343. https:\/\/doi.org\/10.1053\/j.seminhematol.2011.01.002. [cited 2026 Apr 6].","journal-title":"Semin Hematol"},{"key":"2749_CR276","doi-asserted-by":"publisher","DOI":"10.1038\/S41467-021-21588-4","author":"AL Kennedy","year":"2021","unstructured":"Kennedy AL, Myers KC, Bowman J, Gibson CJ, Camarda ND, Furutani E, et al. Distinct genetic pathways define pre-malignant versus compensatory clonal hematopoiesis in Shwachman-Diamond syndrome. Nat Commun. 2021. https:\/\/doi.org\/10.1038\/S41467-021-21588-4. [cited 2026 Apr 6]. 12.","journal-title":"Nat Commun"},{"key":"2749_CR277","doi-asserted-by":"publisher","DOI":"10.1038\/S41467-021-24999-5","author":"S Tan","year":"2021","unstructured":"Tan S, Kermasson L, Hilcenko C, Kargas V, Traynor D, Boukerrou AZ, et al. Somatic genetic rescue of a germline ribosome assembly defect. Nat Commun. 2021. https:\/\/doi.org\/10.1038\/S41467-021-24999-5. [cited 2026 Apr 6]. 12.","journal-title":"Nat Commun"},{"key":"2749_CR278","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1136\/JMEDGENET-2016-104366","volume":"54","author":"P Stepensky","year":"2017","unstructured":"Stepensky P, Chac\u00f3n-Flores M, Kim KH, Abuzaitoun O, Bautista-Santos A, Simanovsky N, et al. Mutations in EFL1, an SBDS partner, are associated with infantile pancytopenia, exocrine pancreatic insufficiency and skeletal anomalies in aShwachman-Diamond like syndrome. J Med Genet. 2017;54:558\u201366. https:\/\/doi.org\/10.1136\/JMEDGENET-2016-104366. [cited 2026 Apr 6].","journal-title":"J Med Genet"},{"key":"2749_CR279","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.ajhg.2016.05.002","volume":"99","author":"H Tummala","year":"2016","unstructured":"Tummala H, Walne AJ, Williams M, Bockett N, Collopy L, Cardoso S, et al. DNAJC21 Mutations Link a Cancer-Prone Bone Marrow Failure Syndrome to Corruption in 60S Ribosome Subunit Maturation. Am J Hum Genet. 2016;99:115\u201324. https:\/\/doi.org\/10.1016\/j.ajhg.2016.05.002. [cited 2026 Apr 6].","journal-title":"Am J Hum Genet"},{"key":"2749_CR280","doi-asserted-by":"publisher","first-page":"4090","DOI":"10.1172\/JCI92876","volume":"127","author":"R Carapito","year":"2017","unstructured":"Carapito R, Konantz M, Paillard C, Miao Z, Pichot A, Leduc MS, et al. Mutations in signal recognition particle SRP54 cause syndromic neutropenia with Shwachman-Diamond-like features. J Clin Invest. 2017;127:4090\u2013103. https:\/\/doi.org\/10.1172\/JCI92876. [cited 2026 Apr 6].","journal-title":"J Clin Invest"},{"key":"2749_CR281","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/251437A0","volume":"251","author":"H Van Den Berghe","year":"1974","unstructured":"Van Den Berghe H, Cassiman JJ, David G, Fryns JP, Michaux JL, Sokal G. Distinct haematological disorder with deletion of long arm of 5 chromosome. Nature. 1974;251:437\u20138. https:\/\/doi.org\/10.1038\/251437A0. [cited 2026 Apr 6].","journal-title":"Nature"},{"key":"2749_CR282","doi-asserted-by":"publisher","first-page":"5803","DOI":"10.1182\/BLOOD-2010-04-273771","volume":"116","author":"J Boultwood","year":"2010","unstructured":"Boultwood J, Pellagatti A, McKenzie ANJ, Wainscoat JS. Advances in the 5q- syndrome. Blood. 2010;116:5803\u201311. https:\/\/doi.org\/10.1182\/BLOOD-2010-04-273771. [cited 2026 Apr 6].","journal-title":"Blood"},{"key":"2749_CR283","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/NATURE06494","volume":"451","author":"BL Ebert","year":"2008","unstructured":"Ebert BL, Pretz J, Bosco J, Chang CY, Tamayo P, Galili N, et al. Identification of RPS14 as a 5q- syndrome gene by RNA interference screen. Nature. 2008;451:335\u20139. https:\/\/doi.org\/10.1038\/NATURE06494. [cited 2026 Apr 6].","journal-title":"Nature"},{"key":"2749_CR284","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/NM.2063","volume":"16","author":"JL Barlow","year":"2010","unstructured":"Barlow JL, Drynan LF, Hewett DR, Holmes LR, Lorenzo-Abalde S, Lane AL, et al. A p53-dependent mechanism underlies macrocytic anemia in a mouse model of human 5q- syndrome. Nat Med. 2010;16:59\u201366. https:\/\/doi.org\/10.1038\/NM.2063. [cited 2026 Apr 6].","journal-title":"Nat Med"},{"key":"2749_CR285","doi-asserted-by":"publisher","first-page":"746","DOI":"10.3324\/HAEMATOL.2019.239970","volume":"106","author":"I Boussaid","year":"2021","unstructured":"Boussaid I, Le Goff S, Floquet C, Gautier EF, Raimbault A, Viailly PJ, et al. Integrated analyses of translatome and proteome identify the rules of translation selectivity in RPS14-deficient cells. Haematologica. 2021;106:746\u201358. https:\/\/doi.org\/10.3324\/HAEMATOL.2019.239970. [cited 2026 Apr 6].","journal-title":"Haematologica"},{"key":"2749_CR286","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/NATURE14610","volume":"523","author":"J Kr\u00f6nke","year":"2015","unstructured":"Kr\u00f6nke J, Fink EC, Hollenbach PW, MacBeth KJ, Hurst SN, Udeshi ND, et al. Lenalidomide induces ubiquitination and degradation of CK1\u03b1 in del(5q) MDS. Nature. 2015;523:183\u20138. https:\/\/doi.org\/10.1038\/NATURE14610. [cited 2026 Apr 6].","journal-title":"Nature"},{"key":"2749_CR287","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.ccr.2014.08.001","volume":"26","author":"RK Schneider","year":"2014","unstructured":"Schneider RK, Adem\u00e0 V, Heckl D, J\u00e4r\u00e5s M, Mallo M, Lord AM, et al. Role of casein kinase 1A1 in the biology and targeted therapy of del(5q) MDS. Cancer Cell. 2014;26:509\u201320. https:\/\/doi.org\/10.1016\/j.ccr.2014.08.001. [cited 2026 Apr 6].","journal-title":"Cancer Cell"},{"key":"2749_CR288","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1200\/JCO.2010.31.8576","volume":"29","author":"M J\u00e4dersten","year":"2011","unstructured":"J\u00e4dersten M, Saft L, Smith A, Kulasekararaj A, Pomplun S, G\u00f6hring G, et al. TP53 mutations in low-risk myelodysplastic syndromes with del(5q) predict disease progression. J Clin Oncol. 2011;29:1971\u20139. https:\/\/doi.org\/10.1200\/JCO.2010.31.8576. [cited 2026 Apr 6].","journal-title":"J Clin Oncol"},{"key":"2749_CR289","doi-asserted-by":"publisher","first-page":"3764","DOI":"10.1182\/BLOOD-2012-03-415349","volume":"120","author":"S Rao","year":"2012","unstructured":"Rao S, Lee SY, Gutierrez A, Perrigoue J, Thapa RJ, Tu Z, et al. Inactivation of ribosomal protein L22 promotes transformation by induction of the stemness factor, Lin28B. Blood. 2012;120:3764\u201373. https:\/\/doi.org\/10.1182\/BLOOD-2012-03-415349. [cited 2026 Apr 6].","journal-title":"Blood"},{"key":"2749_CR290","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1182\/BLOOD-2015-10-674572","volume":"127","author":"V Ljungstr\u00f6m","year":"2015","unstructured":"Ljungstr\u00f6m V, Cortese D, Young E, Pandzic T, Mansouri L, Plevova K, et al. Whole-exome sequencing in relapsing chronic lymphocytic leukemia: clinical impact of recurrent RPS15 mutations. Blood. 2015;127:1007. https:\/\/doi.org\/10.1182\/BLOOD-2015-10-674572. [cited 2026 Apr 6].","journal-title":"Blood"},{"key":"2749_CR291","doi-asserted-by":"publisher","first-page":"14462","DOI":"10.18632\/ONCOTARGET.14895","volume":"8","author":"L Fancello","year":"2017","unstructured":"Fancello L, Kampen KR, Hofman IJF, Verbeeck J, De Keersmaecker K. The ribosomal protein gene RPL5 is a haploinsufficient tumor suppressor in multiple cancer types. Oncotarget. 2017;8:14462\u201378. https:\/\/doi.org\/10.18632\/ONCOTARGET.14895. [cited 2026 Jun 30].","journal-title":"Oncotarget"},{"key":"2749_CR292","doi-asserted-by":"publisher","first-page":"5640","DOI":"10.1073\/PNAS.1400247111","volume":"111","author":"SO Sulima","year":"2014","unstructured":"Sulima SO, Patchett S, Advani VM, De Keersmaecker K, Johnson AW, Dinman JD. Bypass of the pre-60S ribosomal quality control as a pathway to oncogenesis. Proc Natl Acad Sci U S A. 2014;111:5640\u20135. https:\/\/doi.org\/10.1073\/PNAS.1400247111. [cited 2026 Apr 6].","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2749_CR293","doi-asserted-by":"publisher","unstructured":"Astier A, Caruso M, Vereecke S, Santo P, Capron C, Froment C, et al. A RiboCancer cell line panel reveals that CLL-associated Rps15 mutations translationally rewire transcription through codon-specific tRNA accommodation defects. Hemasphere. 2026;10. https:\/\/doi.org\/10.1002\/HEM3.70377. [cited 2026 Jun 30].","DOI":"10.1002\/HEM3.70377"},{"key":"2749_CR294","doi-asserted-by":"publisher","first-page":"3607","DOI":"10.1200\/JCO.2007.15.4906","volume":"26","author":"M J\u00e4dersten","year":"2008","unstructured":"J\u00e4dersten M, Malcovati L, Dybedal I, Della Porta MG, Invernizzi R, Montgomery SM, et al. Erythropoietin and granulocyte-colony stimulating factor treatment associated with improved survival in myelodysplastic syndrome. J Clin Oncol. 2008;26:3607\u201313. https:\/\/doi.org\/10.1200\/JCO.2007.15.4906. [cited 2021 Jun 12].","journal-title":"J Clin Oncol"},{"key":"2749_CR295","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/J.CLML.2013.03.017","volume":"13","author":"HM Kantarjian","year":"2013","unstructured":"Kantarjian HM, O\u2019Brien S, Cortes J. Homoharringtonine\/omacetaxine mepesuccinate: the long and winding road to food and drug administration approval. Clin Lymphoma Myeloma Leuk. 2013;13:530\u20133. https:\/\/doi.org\/10.1016\/J.CLML.2013.03.017. [cited 2026 Apr 6].","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"2749_CR296","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/s41580-023-00661-4","volume":"25","author":"BG Tan","year":"2024","unstructured":"Tan BG, Gustafsson CM, Falkenberg M. Mechanisms and regulation of human mitochondrial transcription. Nat Rev Mol Cell Biol. 2024;25:119\u201332. https:\/\/doi.org\/10.1038\/s41580-023-00661-4.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2749_CR297","doi-asserted-by":"publisher","unstructured":"Bezzerri V, Pegoraro A, Hristodor AM, Crane GM, Meneghelli I, Brignole C, et al. Ataluren improves hematopoietic and pancreatic disorders in Shwachman-Diamond syndrome patients: a compassionate program case-series. Nat Commun. 2025;16. https:\/\/doi.org\/10.1038\/S41467-025-63137-3. [cited 2026 Jun 30].","DOI":"10.1038\/S41467-025-63137-3"},{"key":"2749_CR298","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1056\/NEJMoa1301689","volume":"368","author":"TJ Ley","year":"2013","unstructured":"Cancer Genome Atlas Research Network, Ley TJ, Miller C, Ding L, Raphael BJ, Mungall AJ, et al. Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia. N Engl J Med. 2013;368:2059\u201374. https:\/\/doi.org\/10.1056\/NEJMoa1301689. [cited 2018 May 20].","journal-title":"N Engl J Med"},{"key":"2749_CR299","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1182\/blood.2022016867","volume":"140","author":"H D\u00f6hner","year":"2022","unstructured":"D\u00f6hner H, Wei AH, Appelbaum FR, Craddock C, DiNardo CD, Dombret H, et al. Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN. Blood. 2022;140:1345\u201377. https:\/\/doi.org\/10.1182\/blood.2022016867. [cited 2026 Mar 17].","journal-title":"Blood"},{"key":"2749_CR300","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.molcel.2006.02.009","volume":"21","author":"U Maurer","year":"2006","unstructured":"Maurer U, Charvet C, Wagman AS, Dejardin E, Green DR. Glycogen synthase kinase-3 regulates mitochondrial outer membrane permeabilization and apoptosis by destabilization of MCL-1. Mol Cell. 2006;21:749\u201360. https:\/\/doi.org\/10.1016\/j.molcel.2006.02.009. [cited 2026 Apr 7].","journal-title":"Mol Cell"},{"key":"2749_CR301","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1182\/BLOOD-2016-10-706465","volume":"129","author":"T Girardi","year":"2017","unstructured":"Girardi T, Vicente C, Cools J, De Keersmaecker K. The genetics and molecular biology of T-ALL. Blood. 2017;129:1113\u201323. https:\/\/doi.org\/10.1182\/BLOOD-2016-10-706465. [cited 2026 Apr 7].","journal-title":"Blood"},{"key":"2749_CR302","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1182\/ASHEDUCATION-2012.1.389","volume":"2012","author":"CG Mullighan","year":"2012","unstructured":"Mullighan CG. The molecular genetic makeup of acute lymphoblastic leukemia. Hematol Am Soc Hematol Educ Program. 2012;2012:389\u201396. https:\/\/doi.org\/10.1182\/ASHEDUCATION-2012.1.389. [cited 2026 Apr 7].","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"2749_CR303","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1126\/SCIENCE.1102160","volume":"306","author":"AP Weng","year":"2004","unstructured":"Weng AP, Ferrando AA, Lee W, Morris IVJP, Silverman LB, Sanchez-Irizarry C, et al. Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science. 2004;306:269\u201371. https:\/\/doi.org\/10.1126\/SCIENCE.1102160. [cited 2026 Apr 7].","journal-title":"Science"},{"key":"2749_CR304","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1182\/BLOOD-2016-09-692582","volume":"129","author":"M Sanchez-Martin","year":"2017","unstructured":"Sanchez-Martin M, Ferrando A. The NOTCH1-MYC highway toward T-cell acute lymphoblastic leukemia. Blood. 2017;129:1124\u201333. https:\/\/doi.org\/10.1182\/BLOOD-2016-09-692582. [cited 2026 Apr 7].","journal-title":"Blood"},{"key":"2749_CR305","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1182\/BLOOD-2006-08-039883","volume":"110","author":"SM Chan","year":"2007","unstructured":"Chan SM, Weng AP, Tibshirani R, Aster JC, Utz PJ. Notch signals positively regulate activity of the mTOR pathway in T-cell acute lymphoblastic leukemia. Blood. 2007;110:278\u201386. https:\/\/doi.org\/10.1182\/BLOOD-2006-08-039883. [cited 2026 Apr 7].","journal-title":"Blood"},{"key":"2749_CR306","doi-asserted-by":"publisher","first-page":"5314","DOI":"10.1158\/1078-0432.CCR-07-4864","volume":"14","author":"T Palomero","year":"2008","unstructured":"Palomero T, Ferrando A. Oncogenic NOTCH1 control of MYC and PI3K: challenges and opportunities for anti-NOTCH1 therapy in T-cell acute lymphoblastic leukemias and lymphomas. Clin Cancer Res. 2008;14:5314\u20137. https:\/\/doi.org\/10.1158\/1078-0432.CCR-07-4864. [cited 2026 Apr 7].","journal-title":"Clin Cancer Res"},{"key":"2749_CR307","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1038\/S41375-019-0503-Z","volume":"34","author":"X Zhang","year":"2020","unstructured":"Zhang X, Bi C, Lu T, Zhang W, Yue T, Wang C, et al. Targeting translation initiation by synthetic rocaglates for treating MYC-driven lymphomas. Leukemia. 2020;34:138\u201350. https:\/\/doi.org\/10.1038\/S41375-019-0503-Z. [cited 2026 Apr 7].","journal-title":"Leukemia"},{"key":"2749_CR308","doi-asserted-by":"publisher","unstructured":"Huang Xbo, Yang C, mei, Han Qmei, Ye X, jin, Lei W, Qian W. bin. MNK1 inhibitor CGP57380 overcomes mTOR inhibitor-induced activation of eIF4E: the mechanism of synergic killing of human T-ALL cells. Acta Pharmacol Sin. 2018;39:1894\u2013901. https:\/\/doi.org\/10.1038\/S41401-018-0161-0. [cited 2026 Apr 7].","DOI":"10.1038\/S41401-018-0161-0"},{"key":"2749_CR309","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.cell.2006.11.046","volume":"128","author":"NJ Moerke","year":"2007","unstructured":"Moerke NJ, Aktas H, Chen H, Cantel S, Reibarkh MY, Fahmy A, et al. Small-Molecule Inhibition of the Interaction between the Translation Initiation Factors eIF4E and eIF4G. Cell. 2007;128:257\u201367. https:\/\/doi.org\/10.1016\/j.cell.2006.11.046. [cited 2026 Apr 7].","journal-title":"Cell"},{"key":"2749_CR310","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1182\/BLOOD-2008-10-184515","volume":"114","author":"J Tamburini","year":"2009","unstructured":"Tamburini J, Green AS, Bardet V, Chapuis N, Park S, Willems L, et al. Protein synthesis is resistant to rapamycin and constitutes a promising therapeutic target in acute myeloid leukemia. Blood. 2009;114:1618\u201327. https:\/\/doi.org\/10.1182\/BLOOD-2008-10-184515. [cited 2026 Apr 7].","journal-title":"Blood"},{"key":"2749_CR311","doi-asserted-by":"publisher","DOI":"10.3389\/FONC.2023.1162694","author":"R Buono","year":"2023","unstructured":"Buono R, Alhaddad M, Fruman DA. Novel pharmacological and dietary approaches to target mTOR in B-cell acute lymphoblastic leukemia. Front Oncol. 2023. https:\/\/doi.org\/10.3389\/FONC.2023.1162694. [cited 2026 Apr 7]. 13.","journal-title":"Front Oncol"},{"key":"2749_CR312","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/S12253-014-9861-Z","volume":"21","author":"K Nemes","year":"2015","unstructured":"Nemes K, Cs\u00f3ka M, Nagy N, M\u00e1rk \u00c1, V\u00e1radi Z, Dank\u00f3 T, et al. Expression of certain leukemia\/lymphoma related microRNAs and its correlation with prognosis in childhood acute lymphoblastic leukemia. Pathol Oncol Res. 2015;21:597\u2013604. https:\/\/doi.org\/10.1007\/S12253-014-9861-Z. [cited 2026 Apr 7].","journal-title":"Pathol Oncol Res"},{"key":"2749_CR313","doi-asserted-by":"publisher","first-page":"367","DOI":"10.2165\/00003088-200544040-00003","volume":"44","author":"VI Avramis","year":"2005","unstructured":"Avramis VI, Panosyan EH. Pharmacokinetic\/pharmacodynamic relationships of asparaginase formulations: the past, the present and recommendations for the future. Clin Pharmacokinet. 2005;44:367\u201393. https:\/\/doi.org\/10.2165\/00003088-200544040-00003. [cited 2026 Apr 7].","journal-title":"Clin Pharmacokinet"},{"key":"2749_CR314","doi-asserted-by":"publisher","first-page":"6172","DOI":"10.1182\/BLOOD-2008-02-136762","volume":"113","author":"K Cullion","year":"2009","unstructured":"Cullion K, Draheim KM, Hermance N, Tammam J, Sharma VM, Ware C, et al. Targeting the Notch1 and mTOR pathways in a mouse T-ALL model. Blood. 2009;113:6172\u201381. https:\/\/doi.org\/10.1182\/BLOOD-2008-02-136762. [cited 2026 Apr 7].","journal-title":"Blood"},{"key":"2749_CR315","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/NRCLINONC.2013.197","volume":"11","author":"M Roschewski","year":"2014","unstructured":"Roschewski M, Staudt LM, Wilson WH. Diffuse large B-cell lymphoma-treatment approaches in the molecular era. Nat Rev Clin Oncol. 2014;11:12\u201323. https:\/\/doi.org\/10.1038\/NRCLINONC.2013.197. [cited 2026 Apr 7].","journal-title":"Nat Rev Clin Oncol"},{"key":"2749_CR316","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1056\/NEJMRA0807082","volume":"362","author":"G Lenz","year":"2010","unstructured":"Lenz G, Staudt LM. Aggressive lymphomas. N Engl J Med. 2010;362:1417\u201329. https:\/\/doi.org\/10.1056\/NEJMRA0807082. [cited 2026 Apr 7].","journal-title":"N Engl J Med"},{"key":"2749_CR317","doi-asserted-by":"publisher","first-page":"4600","DOI":"10.1158\/1078-0432.CCR-12-0839","volume":"18","author":"L Alinari","year":"2012","unstructured":"Alinari L, Prince CJ, Edwards RB, Towns WH, Mani R, Lehman A, et al. Dual targeting of the cyclin\/Rb\/E2F and mitochondrial pathways in mantle cell lymphoma with the translation inhibitor silvestrol. Clin Cancer Res. 2012;18:4600\u201311. https:\/\/doi.org\/10.1158\/1078-0432.CCR-12-0839. [cited 2026 Apr 7].","journal-title":"Clin Cancer Res"},{"key":"2749_CR318","doi-asserted-by":"publisher","first-page":"3200","DOI":"10.1038\/SJ.ONC.1207551","volume":"23","author":"M Stoneley","year":"2004","unstructured":"Stoneley M, Willis AE. Cellular internal ribosome entry segments: structures, trans-acting factors and regulation of gene expression. Oncogene. 2004;23:3200\u20137. https:\/\/doi.org\/10.1038\/SJ.ONC.1207551. [cited 2026 Apr 7].","journal-title":"Oncogene"},{"key":"2749_CR319","doi-asserted-by":"publisher","DOI":"10.1186\/S10020-022-00534-0","author":"F Kayastha","year":"2022","unstructured":"Kayastha F, Herrington NB, Kapadia B, Roychowdhury A, Nanaji N, Kellogg GE, et al. Novel eIF4A1 inhibitors with anti-tumor activity in lymphoma. Mol Med. 2022. https:\/\/doi.org\/10.1186\/S10020-022-00534-0. [cited 2026 Apr 7]. 28.","journal-title":"Mol Med"},{"key":"2749_CR320","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.1056\/NEJMOA1400029","volume":"370","author":"JA Woyach","year":"2014","unstructured":"Woyach JA, Furman RR, Liu T-M, Ozer HG, Zapatka M, Ruppert AS, et al. Resistance mechanisms for the Bruton\u2019s tyrosine kinase inhibitor ibrutinib. N Engl J Med. 2014;370:2286\u201394. https:\/\/doi.org\/10.1056\/NEJMOA1400029. [cited 2026 Apr 7].","journal-title":"N Engl J Med"},{"key":"2749_CR321","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1158\/2159-8290.CD-14-0098","volume":"4","author":"D Chiron","year":"2014","unstructured":"Chiron D, Di Liberto M, Martin P, Huang X, Sharman J, Blecua P, et al. Cell-cycle reprogramming for PI3K inhibition overrides a relapse-specific C481S BTK mutation revealed by longitudinal functional genomics in mantle cell lymphoma. Cancer Discov. 2014;4:1022\u201335. https:\/\/doi.org\/10.1158\/2159-8290.CD-14-0098. [cited 2026 Apr 7].","journal-title":"Cancer Discov"},{"key":"2749_CR322","doi-asserted-by":"publisher","first-page":"3884","DOI":"10.1182\/BLOOD-2013-05-498329","volume":"122","author":"G Ott","year":"2013","unstructured":"Ott G, Rosenwald A, Campo E. Understanding MYC-driven aggressive B-cell lymphomas: pathogenesis and classification. Blood. 2013;122:3884\u201391. https:\/\/doi.org\/10.1182\/BLOOD-2013-05-498329. [cited 2026 Apr 7].","journal-title":"Blood"},{"key":"2749_CR323","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1038\/S41416-020-01205-9","volume":"124","author":"Lor Herzog","year":"2021","unstructured":"Herzog Lor, Walters B, Buono R, Lee JS, Mallya S, Fung A, et al. Targeting eIF4F translation initiation complex with SBI-756 sensitises B lymphoma cells to venetoclax. Br J Cancer. 2021;124:1098\u2013109. https:\/\/doi.org\/10.1038\/S41416-020-01205-9. [cited 2026 Apr 7].","journal-title":"Br J Cancer"},{"key":"2749_CR324","doi-asserted-by":"publisher","first-page":"3758","DOI":"10.1182\/BLOOD-2014-07-589689","volume":"124","author":"JJ Steinhardt","year":"2014","unstructured":"Steinhardt JJ, Peroutka RJ, Mazan-Mamczarz K, Chen Q, Houng S, Robles C, et al. Inhibiting CARD11 translation during BCR activation by targeting the eIF4A RNA helicase. Blood. 2014;124:3758. https:\/\/doi.org\/10.1182\/BLOOD-2014-07-589689. [cited 2026 Apr 7].","journal-title":"Blood"},{"key":"2749_CR325","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/NRCLINONC.2016.122","volume":"14","author":"S Manier","year":"2017","unstructured":"Manier S, Salem KZ, Park J, Landau DA, Getz G, Ghobrial IM. Genomic complexity of multiple myeloma and its clinical implications. Nat Rev Clin Oncol. 2017;14:100\u201313. https:\/\/doi.org\/10.1038\/NRCLINONC.2016.122. [cited 2026 Apr 7].","journal-title":"Nat Rev Clin Oncol"},{"key":"2749_CR326","doi-asserted-by":"publisher","unstructured":"Rajkumar SV, Kumar S. Multiple myeloma current treatment algorithms. Blood Cancer J. 2020;10. https:\/\/doi.org\/10.1038\/S41408-020-00359-2. [cited 2026 Apr 7].","DOI":"10.1038\/S41408-020-00359-2"},{"key":"2749_CR327","doi-asserted-by":"publisher","first-page":"4907","DOI":"10.1182\/BLOOD-2005-08-3531","volume":"107","author":"EA Obeng","year":"2006","unstructured":"Obeng EA, Carlson LM, Gutman DM, Harrington WJ, Lee KP, Boise LH. Proteasome inhibitors induce a terminal unfolded protein response in multiple myeloma cells. Blood. 2006;107:4907\u201316. https:\/\/doi.org\/10.1182\/BLOOD-2005-08-3531. [cited 2026 Apr 7].","journal-title":"Blood"},{"key":"2749_CR328","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1158\/0008-5472.CAN-06-2258","volume":"67","author":"S Meister","year":"2007","unstructured":"Meister S, Schubert U, Neubert K, Herrmann K, Burger R, Gramatzki M, et al. Extensive immunoglobulin production sensitizes myeloma cells for proteasome inhibition. Cancer Res. 2007;67:1783\u201392. https:\/\/doi.org\/10.1158\/0008-5472.CAN-06-2258. [cited 2026 Apr 7].","journal-title":"Cancer Res"},{"key":"2749_CR329","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/S12185-016-2016-0","volume":"104","author":"M Ri","year":"2016","unstructured":"Ri M. Endoplasmic-reticulum stress pathway-associated mechanisms of action of proteasome inhibitors in multiple myeloma. Int J Hematol. 2016;104:273\u201380. https:\/\/doi.org\/10.1007\/S12185-016-2016-0. [cited 2026 Apr 7].","journal-title":"Int J Hematol"},{"key":"2749_CR330","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.ccr.2013.08.009","volume":"24","author":"C Leung-Hagesteijn","year":"2013","unstructured":"Leung-Hagesteijn C, Erdmann N, Cheung G, Keats JJ, Stewart AK, Reece DE, et al. Xbp1s-Negative Tumor B Cells and Pre-Plasmablasts Mediate Therapeutic Proteasome Inhibitor Resistance in Multiple Myeloma. Cancer Cell. 2013;24:289\u2013304. https:\/\/doi.org\/10.1016\/j.ccr.2013.08.009. [cited 2026 Apr 7].","journal-title":"Cancer Cell"},{"key":"2749_CR331","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1080\/15548627.2015.1052928","volume":"11","author":"E Milan","year":"2015","unstructured":"Milan E, Perini T, Resnati M, Orfanelli U, Oliva L, Raimondi A, et al. A plastic SQSTM1\/p62-dependent autophagic reserve maintains proteostasis and determines proteasome inhibitor susceptibility in multiple myeloma cells. Autophagy. 2015;11:1161\u201378. https:\/\/doi.org\/10.1080\/15548627.2015.1052928. [cited 2026 Apr 7].","journal-title":"Autophagy"},{"key":"2749_CR332","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1038\/LEU.2011.53","volume":"25","author":"WJ Chng","year":"2011","unstructured":"Chng WJ, Huang GF, Chung TH, Ng SB, Gonzalez-Paz N, Troska-Price T, et al. Clinical and biological implications of MYC activation: a common difference between MGUS and newly diagnosed multiple myeloma. Leukemia. 2011;25:1026\u201335. https:\/\/doi.org\/10.1038\/LEU.2011.53. [cited 2026 Apr 7].","journal-title":"Leukemia"},{"key":"2749_CR333","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/ONC.2017.351","volume":"37","author":"A Visvanathan","year":"2018","unstructured":"Visvanathan A, Patil V, Arora A, Hegde AS, Arivazhagan A, Santosh V, et al. Essential role of METTL3-mediated m6A modification in glioma stem-like cells maintenance and radioresistance. Oncogene. 2018;37:522\u201333. https:\/\/doi.org\/10.1038\/ONC.2017.351. [cited 2026 Apr 7].","journal-title":"Oncogene"},{"key":"2749_CR334","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1126\/SCIENCE.1244851","volume":"343","author":"J Kr\u00f6nke","year":"2014","unstructured":"Kr\u00f6nke J, Udeshi ND, Narla A, Grauman P, Hurst SN, McConkey M, et al. Lenalidomide causes selective degradation of IKZF1 and IKZF3 in multiple myeloma cells. Science. 2014;343:301\u20135. https:\/\/doi.org\/10.1126\/SCIENCE.1244851. [cited 2026 Apr 7].","journal-title":"Science"},{"key":"2749_CR335","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/NI907","volume":"4","author":"NN Iwakoshi","year":"2003","unstructured":"Iwakoshi NN, Lee AH, Vallabhajosyula P, Otipoby KL, Rajewsky K, Glimcher LH. Plasma cell differentiation and the unfolded protein response intersect at the transcription factor XBP-1. Nat Immunol. 2003;4:321\u20139. https:\/\/doi.org\/10.1038\/NI907. [cited 2026 Apr 7].","journal-title":"Nat Immunol"},{"key":"2749_CR336","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/J.CCR.2013.12.009","volume":"25","author":"K Peltonen","year":"2014","unstructured":"Peltonen K, Colis L, Liu H, Trivedi R, Moubarek MS, Moore HM, et al. A targeting modality for destruction of RNA polymerase I that possesses anticancer activity. Cancer Cell. 2014;25:77\u201390. https:\/\/doi.org\/10.1016\/J.CCR.2013.12.009. [cited 2026 Apr 7].","journal-title":"Cancer Cell"},{"key":"2749_CR337","doi-asserted-by":"publisher","first-page":"4151","DOI":"10.1093\/NAR\/GKAE069","volume":"52","author":"JA Espinoza","year":"2024","unstructured":"Espinoza JA, Kanellis DC, Saproo S, Leal K, Martinez JF, Bartek J, et al. Chromatin damage generated by DNA intercalators leads to degradation of RNA Polymerase II. Nucleic Acids Res. 2024;52:4151\u201366. https:\/\/doi.org\/10.1093\/NAR\/GKAE069. [cited 2026 Jun 29].","journal-title":"Nucleic Acids Res"},{"key":"2749_CR338","doi-asserted-by":"publisher","unstructured":"Rosen E, Sharma M, Berz D, Caswell-Jin JL, Spira AI, Fulgar GA, et al. Phase 1\/2 dose expansion study evaluating first-in-class eIF4A inhibitor zotatifin in patients with ER+ metastatic breast cancer. J Clin Oncol. 2023;1080\u20131080. https:\/\/doi.org\/10.1200\/JCO.2023.41.16_SUPPL.1080. [cited 2026 Apr 7].","DOI":"10.1200\/JCO.2023.41.16_SUPPL.1080"},{"key":"2749_CR339","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1182\/BLOOD-2009-02-205153","volume":"114","author":"S Assouline","year":"2009","unstructured":"Assouline S, Culjkovic B, Cocolakis E, Rousseau C, Beslu N, Amri A, et al. Molecular targeting of the oncogene eIF4E in acute myeloid leukemia (AML): a proof-of-principle clinical trial with ribavirin. Blood. 2009;114:257\u201360. https:\/\/doi.org\/10.1182\/BLOOD-2009-02-205153. [cited 2026 Apr 7].","journal-title":"Blood"},{"key":"2749_CR340","doi-asserted-by":"publisher","first-page":"3516","DOI":"10.1021\/ACS.JMEDCHEM.7B01795","volume":"61","author":"SH Reich","year":"2018","unstructured":"Reich SH, Sprengeler PA, Chiang GG, Appleman JR, Chen J, Clarine J, et al. Structure-based Design of Pyridone-Aminal eFT508 Targeting Dysregulated Translation by Selective Mitogen-activated Protein Kinase Interacting Kinases 1 and 2 (MNK1\/2) Inhibition. J Med Chem. 2018;61:3516\u201340. https:\/\/doi.org\/10.1021\/ACS.JMEDCHEM.7B01795. [cited 2026 Apr 7].","journal-title":"J Med Chem"},{"key":"2749_CR341","doi-asserted-by":"publisher","first-page":"3675","DOI":"10.1182\/BLOOD-2013-01-477216","volume":"121","author":"JK Altman","year":"2013","unstructured":"Altman JK, Szilard A, Konicek BW, Iversen PW, Kroczynska B, Glaser H, et al. Inhibition of Mnk kinase activity by cercosporamide and suppressive effects on acute myeloid leukemia precursors. Blood. 2013;121:3675\u201381. https:\/\/doi.org\/10.1182\/BLOOD-2013-01-477216. [cited 2026 Apr 7].","journal-title":"Blood"},{"key":"2749_CR342","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1182\/BLOOD-2015-02-629543","volume":"126","author":"TE Witzig","year":"2015","unstructured":"Witzig TE, Reeder C, Han JJ, LaPlant B, Stenson M, Tun HW, et al. The mTORC1 inhibitor everolimus has antitumor activity in vitro and produces tumor responses in patients with relapsed T-cell lymphoma. Blood. 2015;126:328\u201335. https:\/\/doi.org\/10.1182\/BLOOD-2015-02-629543. [cited 2026 Apr 7].","journal-title":"Blood"},{"key":"2749_CR343","doi-asserted-by":"publisher","first-page":"3822","DOI":"10.1200\/JCO.2008.20.7977","volume":"27","author":"G Hess","year":"2009","unstructured":"Hess G, Herbrecht R, Romaguera J, Verhoef G, Crump M, Gisselbrecht C, et al. Phase III study to evaluate temsirolimus compared with investigator\u2019s choice therapy for the treatment of relapsed or refractory mantle cell lymphoma. J Clin Oncol. 2009;27:3822\u20139. https:\/\/doi.org\/10.1200\/JCO.2008.20.7977. [cited 2026 Apr 7].","journal-title":"J Clin Oncol"},{"key":"2749_CR344","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/NATURE17963","volume":"534","author":"VS Rodrik-Outmezguine","year":"2016","unstructured":"Rodrik-Outmezguine VS, Okaniwa M, Yao Z, Novotny CJ, McWhirter C, Banaji A, et al. Overcoming mTOR resistance mutations with a new-generation mTOR inhibitor. Nature. 2016;534:272\u20136. https:\/\/doi.org\/10.1038\/NATURE17963. [cited 2026 Apr 7].","journal-title":"Nature"},{"key":"2749_CR345","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/S41586-021-03536-W","volume":"593","author":"E Yankova","year":"2021","unstructured":"Yankova E, Blackaby W, Albertella M, Rak J, De Braekeleer E, Tsagkogeorga G, et al. Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia. Nature. 2021;593:597\u2013601. https:\/\/doi.org\/10.1038\/S41586-021-03536-W. [cited 2026 Apr 7].","journal-title":"Nature"},{"key":"2749_CR346","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ccell.2016.11.017","volume":"31","author":"Z Li","year":"2017","unstructured":"Li Z, Weng H, Su R, Weng X, Zuo Z, Li C, et al. FTO Plays an Oncogenic Role in Acute Myeloid Leukemia as a N6-Methyladenosine RNA Demethylase. Cancer Cell. 2017;31:127\u201341. https:\/\/doi.org\/10.1016\/j.ccell.2016.11.017. [cited 2026 Apr 7].","journal-title":"Cancer Cell"},{"key":"2749_CR347","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.cell.2017.11.031","volume":"172","author":"R Su","year":"2018","unstructured":"Su R, Dong L, Li C, Nachtergaele S, Wunderlich M, Qing Y, et al. R-2HG Exhibits Anti-tumor Activity by Targeting FTO\/m6A\/MYC\/CEBPA Signaling. Cell. 2018;172:90\u2013e10523. https:\/\/doi.org\/10.1016\/j.cell.2017.11.031. [cited 2026 Apr 28].","journal-title":"Cell"},{"key":"2749_CR348","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/S41576-020-0258-4","volume":"21","author":"C Buccitelli","year":"2020","unstructured":"Buccitelli C, Selbach M. mRNAs, proteins and the emerging principles of gene expression control. Nat Rev Genet. 2020;21:630\u201344. https:\/\/doi.org\/10.1038\/S41576-020-0258-4. [cited 2026 Apr 7].","journal-title":"Nat Rev Genet"},{"key":"2749_CR349","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1126\/SCIENCE.1168978","volume":"324","author":"NT Ingolia","year":"2009","unstructured":"Ingolia NT, Ghaemmaghami S, Newman JRS, Weissman JS. Genome-wide analysis in vivo of translation with nucleotide resolution using ribosome profiling. Science. 2009;324:218\u201323. https:\/\/doi.org\/10.1126\/SCIENCE.1168978. [cited 2026 Apr 7].","journal-title":"Science"},{"key":"2749_CR350","doi-asserted-by":"publisher","DOI":"10.3324\/HAEMATOL.2025.300149","author":"S Miliara","year":"2026","unstructured":"Miliara S, Zhong X, Papadaki S, Devesa-Serrano D, Farrants A-K, Lehmann S, et al. Decoding the actionable potential of ribosome biogenesis in acute myeloid leukemia. Haematologica. 2026. https:\/\/doi.org\/10.3324\/HAEMATOL.2025.300149. [cited 2026 Jun 29].","journal-title":"Haematologica"},{"key":"2749_CR351","doi-asserted-by":"publisher","first-page":"1644671","DOI":"10.3389\/FIMMU.2025.1644671\/FULL","volume":"16","author":"X Chen","year":"2025","unstructured":"Chen X, Feng A, Chen F, Zeng J, Chen M. Elucidating AML ribosome biogenesis reshaping prognostic assessment and immune microenvironment integrated single-cell and bulk RNA analysis. Front Immunol. 2025;16:1644671. https:\/\/doi.org\/10.3389\/FIMMU.2025.1644671\/FULL. [cited 2026 Jun 29].","journal-title":"Front Immunol"},{"key":"2749_CR352","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/35000501","volume":"403","author":"AA Alizadeh","year":"2000","unstructured":"Alizadeh AA, Elsen MB, Davis RE, Ma CL, Lossos IS, Rosenwald A, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature. 2000;403:503\u201311. https:\/\/doi.org\/10.1038\/35000501. [cited 2026 Apr 7].","journal-title":"Nature"},{"key":"2749_CR353","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.cell.2009.02.024","volume":"136","author":"J Luo","year":"2009","unstructured":"Luo J, Solimini NL, Elledge SJ. Principles of Cancer Therapy: Oncogene and Non-oncogene Addiction. Cell. 2009;136:823\u201337. https:\/\/doi.org\/10.1016\/j.cell.2009.02.024. [cited 2026 Apr 7].","journal-title":"Cell"},{"key":"2749_CR354","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/S41586-020-2497-0","volume":"585","author":"KJ Abraham","year":"2020","unstructured":"Abraham KJ, Khosraviani N, Chan JNY, Gorthi A, Samman A, Zhao DY, et al. Nucleolar RNA polymerase II drives ribosome biogenesis. Nature. 2020;585:298\u2013302. https:\/\/doi.org\/10.1038\/S41586-020-2497-0. [cited 2026 Jun 29].","journal-title":"Nature"},{"key":"2749_CR355","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/NRM4069","volume":"16","author":"GA Brar","year":"2015","unstructured":"Brar GA, Weissman JS. Ribosome profiling reveals the what, when, where and how of protein synthesis. Nat Rev Mol Cell Biol. 2015;16:651\u201364. https:\/\/doi.org\/10.1038\/NRM4069. [cited 2026 Apr 7].","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2749_CR356","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/S41586-021-03887-4","volume":"597","author":"M VanInsberghe","year":"2021","unstructured":"VanInsberghe M, van den Berg J, Andersson-Rolf A, Clevers H, van Oudenaarden A. Single-cell Ribo-seq reveals cell cycle-dependent translational pausing. Nature. 2021;597:561\u20135. https:\/\/doi.org\/10.1038\/S41586-021-03887-4. [cited 2026 Apr 7].","journal-title":"Nature"}],"container-title":["Molecular Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12943-026-02749-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-026-02749-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-026-02749-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T13:03:37Z","timestamp":1792587817000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12943-026-02749-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,23]]},"references-count":356,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2749"],"URL":"https:\/\/doi.org\/10.1186\/s12943-026-02749-9","relation":{},"ISSN":["1476-4598"],"issn-type":[{"value":"1476-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,23]]},"assertion":[{"value":"2 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This Review did not involve new studies in human participants or animals and did not use identifiable patient data; therefore, ethics approval and consent were not required.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"During the preparation of this work, the authors utilized Gemini to assist with figure generation. Following its use, the author thoroughly reviewed and edited the content as necessary, taking full responsibility for the accuracy and integrity of the publication.","order":3,"name":"Ethics","label":"Generative AI statement","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"249"}}